Document
0470.01false--12-31Q12020000072789201700000025000000191110000001897400000003030100000100000100000100000100000100000130000000.0170.0120.01230.200.150.1528110000000.00650.00650.00650.02100.02100.02100.02100.02100.02100.02100.021000001500000000110000001000000012000000720000000 0000727892 2020-01-01 2020-03-31 0000727892 2020-05-11 0000727892 2020-03-31 0000727892 2019-12-31 0000727892 2019-01-01 2019-03-31 0000727892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000727892 us-gaap:RetainedEarningsMember 2018-12-31 0000727892 us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0000727892 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000727892 2018-12-31 0000727892 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000727892 us-gaap:RetainedEarningsMember 2020-03-31 0000727892 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000727892 us-gaap:RetainedEarningsMember 2019-03-31 0000727892 us-gaap:RetainedEarningsMember 2019-12-31 0000727892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000727892 2019-03-31 0000727892 us-gaap:CommonStockMember 2019-03-31 0000727892 us-gaap:CommonStockMember 2020-03-31 0000727892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000727892 us-gaap:CommonStockMember 2019-12-31 0000727892 us-gaap:AccountingStandardsUpdate201613Member us-gaap:RetainedEarningsMember 2019-12-31 0000727892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000727892 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000727892 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000727892 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000727892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000727892 us-gaap:AccountingStandardsUpdate201708Member 2018-12-31 0000727892 us-gaap:AccountingStandardsUpdate201708Member us-gaap:RetainedEarningsMember 2018-12-31 0000727892 us-gaap:CommonStockMember 2018-12-31 0000727892 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000727892 us-gaap:DistributionServiceMember amp:UnaffiliatedMember 2019-01-01 2019-03-31 0000727892 us-gaap:AdministrativeServiceMember 2020-01-01 2020-03-31 0000727892 us-gaap:DistributionServiceMember 2020-01-01 2020-03-31 0000727892 us-gaap:DistributionServiceMember amp:UnaffiliatedMember 2020-01-01 2020-03-31 0000727892 amp:InsuranceCommissionsandFeesMember srt:AffiliatedEntityMember 2019-01-01 2019-03-31 0000727892 us-gaap:DistributionServiceMember 2019-01-01 2019-03-31 0000727892 us-gaap:FinancialServiceMember 2020-01-01 2020-03-31 0000727892 us-gaap:AdministrativeServiceMember 2019-01-01 2019-03-31 0000727892 us-gaap:AdministrativeServiceMember amp:UnaffiliatedMember 2019-01-01 2019-03-31 0000727892 amp:InsuranceCommissionsandFeesMember amp:UnaffiliatedMember 2020-01-01 2020-03-31 0000727892 us-gaap:AdministrativeServiceMember srt:AffiliatedEntityMember 2019-01-01 2019-03-31 0000727892 us-gaap:DistributionServiceMember srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000727892 amp:InsuranceCommissionsandFeesMember srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000727892 us-gaap:AdministrativeServiceMember srt:AffiliatedEntityMember 2020-01-01 2020-03-31 0000727892 us-gaap:DistributionServiceMember srt:AffiliatedEntityMember 2019-01-01 2019-03-31 0000727892 amp:InsuranceCommissionsandFeesMember amp:UnaffiliatedMember 2019-01-01 2019-03-31 0000727892 us-gaap:FinancialServiceMember 2019-01-01 2019-03-31 0000727892 amp:InsuranceCommissionsandFeesMember 2019-01-01 2019-03-31 0000727892 us-gaap:AdministrativeServiceMember amp:UnaffiliatedMember 2020-01-01 2020-03-31 0000727892 amp:InsuranceCommissionsandFeesMember 2020-01-01 2020-03-31 0000727892 amp:RiverSourceTaxAdvantagedInvestmentsIncMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-12-31 0000727892 amp:RiverSourceTaxAdvantagedInvestmentsIncMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-03-31 0000727892 us-gaap:FixedMaturitiesMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-01-01 2020-03-31 0000727892 us-gaap:FixedMaturitiesMember 2020-03-31 0000727892 amp:AmeripriseAdvisorFinancingLLCMember 2019-12-31 0000727892 us-gaap:FixedMaturitiesMember 2019-12-31 0000727892 us-gaap:USTreasuryAndGovernmentMember 2020-03-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2020-03-31 0000727892 us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-03-31 0000727892 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-12-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000727892 amp:CreditRatingAMember 2019-12-31 0000727892 amp:CreditRatingAMember 2020-03-31 0000727892 amp:CreditRatingBBBMember 2020-03-31 0000727892 amp:CreditRatingBelowInvestmentGradeMember 2019-12-31 0000727892 amp:CreditRatingBBBMember 2019-12-31 0000727892 amp:CreditRatingAAMember 2019-12-31 0000727892 amp:CreditRatingAAAMember 2019-12-31 0000727892 amp:CreditRatingBelowInvestmentGradeMember 2020-03-31 0000727892 amp:CreditRatingAAMember 2020-03-31 0000727892 amp:CreditRatingAAAMember 2020-03-31 0000727892 us-gaap:MortgagesMember 2020-01-01 2020-03-31 0000727892 us-gaap:OtherInvestmentsMember 2019-01-01 2019-03-31 0000727892 us-gaap:FixedMaturitiesMember 2020-01-01 2020-03-31 0000727892 us-gaap:FixedMaturitiesMember 2019-01-01 2019-03-31 0000727892 us-gaap:OtherInvestmentsMember 2020-01-01 2020-03-31 0000727892 us-gaap:MortgagesMember 2019-01-01 2019-03-31 0000727892 amp:SyndicatedLoansMember 2020-01-01 2020-03-31 0000727892 us-gaap:CommercialRealEstateMember 2020-03-31 0000727892 amp:SyndicatedLoansMember 2019-12-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:SyndicatedLoansMember 2020-03-31 0000727892 amp:SyndicatedLoansMember 2019-01-01 2019-03-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember amp:DebttoValue40to60PercentMember 2020-03-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember amp:DebttoValue60to80PercentMember 2020-03-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember amp:DebttoValueRatioGreaterthan100PercentMember 2020-03-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember us-gaap:Ltv80To100PercentMember 2020-03-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember amp:DebttoValueLessthan40PercentMember 2020-03-31 0000727892 us-gaap:CommercialRealEstateMember 2019-01-01 2019-03-31 0000727892 us-gaap:CommercialRealEstateMember 2018-12-31 0000727892 us-gaap:CommercialRealEstateMember 2019-03-31 0000727892 amp:SyndicatedLoansMember amp:InternalRiskRating2Member 2020-03-31 0000727892 amp:SyndicatedLoansMember amp:InternalRiskRating1Member 2020-03-31 0000727892 amp:SyndicatedLoansMember amp:InternalRiskRating3Member 2020-03-31 0000727892 amp:SyndicatedLoansMember amp:InternalRiskRating5Member 2020-03-31 0000727892 amp:SyndicatedLoansMember amp:InternalRiskRating4Member 2020-03-31 0000727892 amp:WestSouthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:WestSouthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:EastNorthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:EastNorthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:MiddleAtlanticMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:NewEnglandMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:SouthAtlanticMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:WestNorthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:MiddleAtlanticMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:MountainMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:MountainMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:EastSouthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:NewEnglandMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:SouthAtlanticMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:PacificMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:WestNorthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:EastSouthCentralMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:PacificMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 amp:MixedUseMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 srt:IndustrialPropertyMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 srt:HotelMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 amp:MixedUseMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:RetailSiteMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:OtherPropertyMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:IndustrialPropertyMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:ApartmentBuildingMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 srt:OfficeBuildingMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:HotelMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:ApartmentBuildingMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-03-31 0000727892 srt:OfficeBuildingMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 srt:OtherPropertyMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 srt:RetailSiteMember us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0000727892 us-gaap:CommercialRealEstateMember 2020-01-01 0000727892 us-gaap:AccountingStandardsUpdate201613Member us-gaap:CommercialRealEstateMember 2020-01-01 0000727892 us-gaap:CommercialRealEstateMember 2019-12-31 0000727892 us-gaap:CommercialRealEstateMember 2020-01-01 2020-03-31 0000727892 amp:FixedannuitieslifecontingentliabilitiesMember 2020-03-31 0000727892 amp:VULULandotherlifeinsuranceadditionalliabilitiesMember 2020-03-31 0000727892 amp:VariableUniversalLifeAndUniversalLifeInsuranceMember 2020-03-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2019-12-31 0000727892 amp:OtherLifeInsuranceMember 2020-03-31 0000727892 us-gaap:VariableAnnuityMember 2020-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-03-31 0000727892 us-gaap:VariableAnnuityMember 2019-12-31 0000727892 amp:IndexedUniversalLifeMember 2019-12-31 0000727892 us-gaap:FixedAnnuityMember 2019-12-31 0000727892 amp:IndexedUniversalLifeMember 2020-03-31 0000727892 amp:FixedannuitieslifecontingentliabilitiesMember 2019-12-31 0000727892 amp:OtherVariableAnnuityGuaranteesMember 2020-03-31 0000727892 amp:LifeandDisabilityIncomeInsuranceMember 2020-03-31 0000727892 amp:LifeandDisabilityIncomeInsuranceMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2020-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-12-31 0000727892 amp:LongtermcareinsuranceMember 2019-12-31 0000727892 amp:OtherVariableAnnuityGuaranteesMember 2019-12-31 0000727892 amp:VULULandotherlifeinsuranceadditionalliabilitiesMember 2019-12-31 0000727892 us-gaap:FixedAnnuityMember 2020-03-31 0000727892 amp:VariableUniversalLifeAndUniversalLifeInsuranceMember 2019-12-31 0000727892 amp:LongtermcareinsuranceMember 2020-03-31 0000727892 amp:OtherLifeInsuranceMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-03-31 0000727892 amp:GuaranteedMinimumUniversalLifeMember 2019-01-01 2019-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember 2019-01-01 2019-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumUniversalLifeMember 2018-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember 2019-03-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-01-01 2019-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2018-12-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2019-01-01 2019-03-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2018-12-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-01-01 2019-03-31 0000727892 amp:GuaranteedMinimumUniversalLifeMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-03-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumUniversalLifeMember 2019-03-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2019-03-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2018-12-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitAndGainGrossUpMember 2018-12-31 0000727892 amp:GuaranteedMinimumUniversalLifeMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumUniversalLifeMember 2020-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-12-31 0000727892 amp:ULSecondaryGuaranteesMember 2020-01-01 2020-03-31 0000727892 amp:ULSecondaryGuaranteesMember 2020-03-31 0000727892 amp:ULSecondaryGuaranteesMember 2019-12-31 0000727892 amp:ULSecondaryGuaranteesMember 2019-01-01 2019-12-31 0000727892 us-gaap:EquityFundsMember 2019-12-31 0000727892 us-gaap:FixedIncomeFundsMember 2020-03-31 0000727892 amp:OtherMutualFundsMember 2020-03-31 0000727892 us-gaap:MutualFundMember 2020-03-31 0000727892 us-gaap:EquityFundsMember 2020-03-31 0000727892 us-gaap:MutualFundMember 2019-12-31 0000727892 us-gaap:FixedIncomeFundsMember 2019-12-31 0000727892 amp:OtherMutualFundsMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumDeathBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0000727892 us-gaap:GuaranteedLifetimeWithdrawalBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumWithdrawalStandardBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-03-31 0000727892 us-gaap:GuaranteedMinimumAccumulationBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitOtherMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitGainGrossUpMember 2019-12-31 0000727892 us-gaap:GuaranteedLifetimeWithdrawalBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitOtherMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitOtherMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedLifetimeWithdrawalBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedLifetimeWithdrawalBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumWithdrawalStandardBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0000727892 us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumWithdrawalStandardBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitGainGrossUpMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveOrSixYearResetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0000727892 us-gaap:GuaranteedMinimumDeathBenefitMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0000727892 amp:GuaranteedMinimumWithdrawalStandardBenefitMember us-gaap:GuaranteedMinimumWithdrawalBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitGainGrossUpMember 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitFiveYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitOneYearRatchetMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitOtherMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0000727892 amp:GuaranteedMinimumDeathBenefitReturnOfPremiumMember us-gaap:GuaranteedMinimumDeathBenefitMember 2020-01-01 2020-03-31 0000727892 amp:GuaranteedMinimumDeathBenefitGainGrossUpMember 2020-01-01 2020-03-31 0000727892 us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0000727892 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FederalHomeLoanBankAdvancesMember 2020-03-31 0000727892 us-gaap:FederalHomeLoanBankAdvancesMember 2020-03-31 0000727892 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FederalHomeLoanBankAdvancesMember 2019-12-31 0000727892 us-gaap:FederalHomeLoanBankAdvancesMember 2020-01-01 2020-03-31 0000727892 us-gaap:FederalHomeLoanBankAdvancesMember 2019-01-01 2019-12-31 0000727892 us-gaap:FederalHomeLoanBankAdvancesMember 2019-12-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:StructuredannuityembeddedderivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:StructuredannuityembeddedderivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:MeasurementInputLossSeverityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:StructuredannuityembeddedderivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:MeasurementInputDefaultRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:MeasurementInputDefaultRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:MeasurementInputLossSeverityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember amp:MeasurementInputYieldandSpreadtoTreasuryMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:StructuredannuityembeddedderivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember amp:MeasurementInputYieldandSpreadtoTreasuryMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember amp:MeasurementInputYieldandSpreadtoTreasuryMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:AvailableforsaleSecuritiesMember 2020-01-01 2020-03-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2020-01-01 2020-03-31 0000727892 us-gaap:AvailableforsaleSecuritiesMember 2019-12-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2020-01-01 2020-03-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-12-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2020-03-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:StructuredannuityembeddedderivativesMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:StructuredannuityembeddedderivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember 2020-01-01 2020-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2020-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember 2020-01-01 2020-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2020-01-01 2020-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember 2019-12-31 0000727892 amp:StructuredannuityembeddedderivativesMember 2020-01-01 2020-03-31 0000727892 amp:StructuredannuityembeddedderivativesMember 2020-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember 2019-12-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember 2020-01-01 2020-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2019-12-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember 2020-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember 2020-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember 2019-12-31 0000727892 amp:StructuredannuityembeddedderivativesMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember 2020-03-31 0000727892 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember 2019-01-01 2019-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember 2018-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2019-01-01 2019-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember 2019-01-01 2019-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember 2018-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2018-12-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember 2019-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember 2019-01-01 2019-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember 2018-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2019-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember 2019-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember 2019-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-03-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2020-03-31 0000727892 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-03-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000727892 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-12-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0000727892 us-gaap:EquityContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-12-31 0000727892 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-12-31 0000727892 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0000727892 amp:RiverSourceTaxAdvantagedInvestmentsIncMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2020-03-31 0000727892 2019-01-01 2019-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember 2019-12-31 0000727892 amp:RiverSourceTaxAdvantagedInvestmentsIncMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember amp:MeasurementInputYieldandSpreadtoTreasuryMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember amp:MeasurementInputYieldandSpreadtoTreasuryMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:MeasurementInputDefaultRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember amp:MeasurementInputYieldandSpreadtoTreasuryMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:MeasurementInputLossSeverityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputSurrenderRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember amp:MeasurementInputUtilizationofGuaranteedWithdrawalsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2019-01-01 2019-03-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0000727892 us-gaap:AvailableforsaleSecuritiesMember 2019-01-01 2019-03-31 0000727892 us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-01-01 2019-03-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-03-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-01-01 2019-03-31 0000727892 us-gaap:ResidentialMortgageBackedSecuritiesMember 2018-12-31 0000727892 us-gaap:AvailableforsaleSecuritiesMember 2019-03-31 0000727892 us-gaap:AvailableforsaleSecuritiesMember 2018-12-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2018-12-31 0000727892 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember 2019-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:StructuredannuityembeddedderivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedUniversalLifeEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:StructuredannuityembeddedderivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:IndexedAnnuitiesEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:FairValueInputsLevel3Member amp:GMWBAndGMABEmbeddedDerivativesMember us-gaap:MeasurementInputCounterpartyCreditRiskMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember amp:MeasurementInputYieldandSpreadtoSwapRatesDomain us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember amp:MeasurementInputYieldandSpreadtoSwapRatesDomain us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember amp:MeasurementInputYieldandSpreadtoSwapRatesDomain us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember amp:MeasurementInputYieldandSpreadtoSwapRatesDomain us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember amp:MeasurementInputYieldandSpreadtoSwapRatesDomain us-gaap:ValuationTechniqueDiscountedCashFlowMember 2019-12-31 0000727892 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember amp:MeasurementInputYieldandSpreadtoSwapRatesDomain us-gaap:ValuationTechniqueDiscountedCashFlowMember 2020-03-31 0000727892 us-gaap:OverTheCounterMember 2020-03-31 0000727892 us-gaap:ExchangeTradedMember 2020-03-31 0000727892 us-gaap:ExchangeClearedMember 2020-03-31 0000727892 amp:TotalOvertheCounterDerivativesMember 2020-03-31 0000727892 us-gaap:ExchangeClearedMember 2019-12-31 0000727892 us-gaap:OverTheCounterMember 2019-12-31 0000727892 us-gaap:ExchangeTradedMember 2019-12-31 0000727892 amp:TotalOvertheCounterDerivativesMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:IndexedUniversalLifeEmbeddedDerivativesMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:IndexedAnnuitiesEmbeddedDerivativesMember 2020-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:EquityContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:NondesignatedMember 2020-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:GMWBAndGMABEmbeddedDerivativesMember 2019-12-31 0000727892 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2020-03-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:IndexedAnnuitiesEmbeddedDerivativesMember 2019-12-31 0000727892 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:GMWBAndGMABEmbeddedDerivativesMember 2020-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2019-12-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherAssetsMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherAssetsMember us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:IndexedUniversalLifeEmbeddedDerivativesMember 2020-03-31 0000727892 us-gaap:OtherAssetsMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherAssetsMember us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherAssetsMember us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 amp:PolicyholderAccountBalancesFuturePolicyBenefitsandClaimsMember amp:StructuredannuityembeddedderivativesMember 2020-03-31 0000727892 us-gaap:EquityContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherAssetsMember us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherAssetsMember us-gaap:EquityContractMember us-gaap:NondesignatedMember 2020-03-31 0000727892 us-gaap:OtherLiabilitiesMember us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember 2019-12-31 0000727892 us-gaap:EquityContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2019-01-01 2019-03-31 0000727892 us-gaap:EquityContractMember us-gaap:NondesignatedMember amp:InterestCreditedToFixedAccountsMember 2019-01-01 2019-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:InterestCreditedToFixedAccountsMember 2019-01-01 2019-03-31 0000727892 amp:InterestCreditedToFixedAccountsMember 2019-01-01 2019-03-31 0000727892 amp:BenefitsClaimsLossesAndSettlementExpensesMember 2019-01-01 2019-03-31 0000727892 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2019-01-01 2019-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2019-01-01 2019-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2019-01-01 2019-03-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2019-01-01 2019-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember amp:InterestCreditedToFixedAccountsMember 2019-01-01 2019-03-31 0000727892 us-gaap:EquityContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 amp:GMWBAndGMABEmbeddedDerivativesMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 us-gaap:CreditRiskContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 amp:InterestCreditedToFixedAccountsMember 2020-01-01 2020-03-31 0000727892 amp:IndexedAnnuitiesEmbeddedDerivativesMember amp:InterestCreditedToFixedAccountsMember 2020-01-01 2020-03-31 0000727892 us-gaap:EquityContractMember us-gaap:NondesignatedMember amp:InterestCreditedToFixedAccountsMember 2020-01-01 2020-03-31 0000727892 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 amp:IndexedUniversalLifeEmbeddedDerivativesMember amp:InterestCreditedToFixedAccountsMember 2020-01-01 2020-03-31 0000727892 amp:StructuredannuityembeddedderivativesMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 amp:BenefitsClaimsLossesAndSettlementExpensesMember 2020-01-01 2020-03-31 0000727892 amp:DueAfterFourYearsMember 2020-03-31 0000727892 amp:DueInOneYearMember 2020-03-31 0000727892 amp:CurrentYearMember 2020-03-31 0000727892 amp:DueInTwoYearsMember 2020-03-31 0000727892 amp:DueInThreeYearsMember 2020-03-31 0000727892 amp:DueInFourYearsMember 2020-03-31 0000727892 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0000727892 amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember 2019-12-31 0000727892 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000727892 amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember 2020-01-01 2020-03-31 0000727892 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000727892 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000727892 amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember 2020-03-31 0000727892 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-03-31 0000727892 amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember 2019-01-01 2019-03-31 0000727892 amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember 2019-03-31 0000727892 amp:AccumulatedNetUnrealizedFromOtherInvestmentGainLossMember 2018-12-31 0000727892 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000727892 us-gaap:StateAndLocalJurisdictionMember 2020-03-31 0000727892 us-gaap:InsuranceRelatedAssessmentsMember 2020-03-31 0000727892 us-gaap:InsuranceRelatedAssessmentsMember 2020-01-01 2020-03-31 0000727892 us-gaap:InsuranceRelatedAssessmentsMember 2019-01-01 2019-12-31 0000727892 us-gaap:InsuranceRelatedAssessmentsMember 2019-12-31 iso4217:USD xbrli:shares amp:item xbrli:shares xbrli:pure iso4217:USD
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM
10-Q
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended
March 31, 2020
OR
 
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from_______________________to_______________________
Commission File No.
033-28976
RIVERSOURCE LIFE INSURANCE COMPANY
(Exact name of registrant as specified in its charter)
 
Minnesota
 
41-0823832
 
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
1099 Ameriprise Financial Center
 
Minneapolis
 
Minnesota
 
55474
 
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code:
(612)
671-3131
 
 
Former name, former address and former fiscal year, if changed since last report:
Not Applicable
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days  
Yes
No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-accelerated Filer
Smaller reporting company
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  
Yes
No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
Class
 
Outstanding at May 11, 2020
 
Common Stock (par value $30 per share)
100,000 shares
 
THE REGISTRANT MEETS THE CONDITIONS SET FORTH IN GENERAL INSTRUCTIONS H(1) (a) AND (b) OF FORM 10-Q AND IS THEREFORE FILING THIS FORM WITH THE REDUCED DISCLOSURE FORMAT.
 
 



RIVERSOURCE LIFE INSURANCE COMPANY

FORM 10-Q
INDEX
Part I. Financial Information
 
Item 1. Financial Statements (Unaudited)
 

Consolidated Balance Sheets — March 31, 2020 and December 31, 2019

Consolidated Statements of Income — Three months ended March 31, 2020 and 2019

Consolidated Statements of Comprehensive Income — Three months ended March 31, 2020 and 2019

Consolidated Statements of Shareholder’s Equity — Three months ended March 31, 2020 and 2019

Consolidated Statements of Cash Flows — Three months ended March 31, 2020 and 2019
 
Notes to Consolidated Financial Statements
 
1.
Basis of Presentation
 
2.
Summary of Significant Accounting Policies
 
 
3.
Recent Accounting Pronouncements
 
4.
Revenue from Contracts with Customers
 
5.
Variable Interest Entities
 
6.
Investments
 
7.
Financing Receivables
 
8.
Deferred Acquisition Costs and Deferred Sales Inducement Costs
 
9.
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities
 
10.
Variable Annuity and Insurance Guarantees
 
11.
Short-term Borrowings
 
12.
Fair Values of Assets and Liabilities
 
13.
Offsetting Assets and Liabilities
 
14.
Derivatives and Hedging Activities
 
15.
Shareholders’ Equity
 
16.
Income Taxes
 
17.
Contingencies
Item 2.  Management’s Narrative Analysis
Item 4.  Controls and Procedures
 
 
Part II.  Other Information
Item 1.  Legal Proceedings
Item 1A.  Risk Factors
Item 6.  Exhibits
Signatures


2



RIVERSOURCE LIFE INSURANCE COMPANY

PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS 
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
 
March 31,
2020
 
December 31,
2019
(in millions, except share amounts)
Assets
 
 
 
Investments:
 
 
 
Available-for-Sale: Fixed maturities, at fair value (amortized cost: 2020, $18,974; 2019, $19,111) (net of allowance for credit losses: 2020, $13 (1))
$
19,742

 
$
20,902

Mortgage loans, at amortized cost (net of allowance for credit losses: 2020, $25; 2019, $17)
2,653

 
2,655

Policy loans
869

 
867

Other investments (net of allowance for credit losses: 2020, $7; 2019, $4)
723

 
734

Total investments
23,987

 
25,158

Cash and cash equivalents
5,056

 
1,275

Reinsurance recoverables (net of allowance for credit losses: 2020, $7 (1))
3,214

 
3,198

Other receivables
1,682

 
1,713

Accrued investment income
175

 
169

Deferred acquisition costs
2,345

 
2,673

Other assets
7,770

 
5,332

Separate account assets
70,842

 
82,425

Total assets
$
115,071

 
$
121,943

 
 
 
 
Liabilities and Shareholder’s Equity
 
 
 
Liabilities:
 
 
 
Policyholder account balances, future policy benefits and claims
$
32,677

 
$
30,504

Short-term borrowings
200

 
201

Line of credit with Ameriprise Financial, Inc.

 
50

Other liabilities
6,874

 
5,427

Separate account liabilities
70,842

 
82,425

Total liabilities
110,593

 
118,607

 
 
 
 
Shareholder’s equity:
 
 
 
Common stock, $30 par value; 100,000 shares authorized, issued and outstanding
3

 
3

Additional paid-in capital
2,466

 
2,466

Retained earnings
1,830

 
293

Accumulated other comprehensive income, net of tax
179

 
574

Total shareholder’s equity
4,478

 
3,336

Total liabilities and shareholder’s equity
$
115,071

 
$
121,943

(1) Prior to January 1, 2020, the allowance for credit losses is not applicable to Available-for-Sale securities and Reinsurance recoverables. See Notes 2, 3, 6 and 7 for more information.
See Notes to Consolidated Financial Statements.

3



RIVERSOURCE LIFE INSURANCE COMPANY

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Revenues
 
 
 
Premiums
$
93

 
$
103

Net investment income
223

 
256

Policy and contract charges
551

 
473

Other revenues
119

 
102

Net realized investment gains (losses)
(17
)
 
10

Total revenues
969

 
944

Benefits and expenses
 
 
 
Benefits, claims, losses and settlement expenses
(1,748
)
 
418

Interest credited to fixed accounts
91

 
204

Amortization of deferred acquisition costs
503

 
2

Other insurance and operating expenses
163

 
168

Total benefits and expenses
(991
)
 
792

Pretax income (loss)
1,960

 
152

Income tax provision (benefit)
166

 
7

Net income
$
1,794

 
$
145


See Notes to Consolidated Financial Statements.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Net income
$
1,794

 
$
145

Other comprehensive income (loss), net of tax:
 
 
 
Net unrealized gains (losses) on securities
(395
)
 
272

Total other comprehensive income (loss), net of tax
(395
)
 
272

Total comprehensive income
$
1,399

 
$
417

See Notes to Consolidated Financial Statements.

4



RIVERSOURCE LIFE INSURANCE COMPANY

CONSOLIDATED STATEMENTS OF SHAREHOLDER’S EQUITY (UNAUDITED)

 
Common Shares
 
Additional Paid-In Capital
 
Retained Earnings
 
Accumulated Other 
Comprehensive Income (Loss)
 
Total
(in millions)
Balances at January 1, 2019
$
3

 
$
2,466

 
$
1,058

 
$
45

 
$
3,572

Cumulative effect of adoption of premium amortization on purchased callable debt securities guidance

 

 
(2
)
 

 
(2
)
Comprehensive income:
 
 
 
 
 
 
 
 
 
Net income

 

 
145

 

 
145

Other comprehensive income (loss), net of tax

 

 

 
272

 
272

Total comprehensive income
 
 
 
 
 
 
 
 
417

Cash dividends to Ameriprise Financial, Inc.

 

 
(250
)
 

 
(250
)
Balances at March 31, 2019
$
3

 
$
2,466

 
$
951

 
$
317

 
$
3,737

 
 
 
 
 
 
 
 
 
 
Balances at January 1, 2020
$
3

 
$
2,466

 
$
293

 
$
574

 
$
3,336

Cumulative effect of adoption of current expected credit losses guidance

 

 
(7
)
 

 
(7
)
Comprehensive income:
 
 
 
 
 
 
 
 
 
Net income

 

 
1,794

 

 
1,794

Other comprehensive income (loss), net of tax

 

 

 
(395
)
 
(395
)
Total comprehensive income
 
 
 
 
 
 
 
 
1,399

Cash dividends to Ameriprise Financial, Inc.

 

 
(250
)
 

 
(250
)
Balances at March 31, 2020
$
3

 
$
2,466

 
$
1,830

 
$
179

 
$
4,478


See Notes to Consolidated Financial Statements.

5



RIVERSOURCE LIFE INSURANCE COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Cash Flows from Operating Activities
 
 
 
Net income
$
1,794

 
$
145

Adjustments to reconcile net income to net cash provided by (used in) operating activities:
 

 
 

Depreciation, amortization and accretion, net
(9
)
 
5

Deferred income tax (benefit) expense
1,209

 
(21
)
Contractholder and policyholder charges, non-cash
(96
)
 
(95
)
Loss from equity method investments
16

 
16

Net realized investment (gains) losses
(4
)
 
(10
)
Impairments and provision for loan losses
21

 

Changes in operating assets and liabilities:
 

 
 

Deferred acquisition costs
446

 
(52
)
Policyholder account balances, future policy benefits and claims, net
2,730

 
(100
)
Derivatives, net of collateral
(745
)
 
296

Reinsurance recoverables
(19
)
 
(14
)
Other receivables
14

 
(10
)
Accrued investment income
(6
)
 
(3
)
Current income tax expense (benefit)
(1,086
)
 
(3
)
Other, net
40

 
23

Net cash provided by (used in) operating activities
4,305

 
177

 
 
 
 
Cash Flows from Investing Activities
 
 
 
Available-for-Sale securities:
 
 
 
Proceeds from sales
79

 
82

Maturities, sinking fund payments and calls
474

 
645

Purchases
(413
)
 
(511
)
Proceeds from sales, maturities and repayments of mortgage loans
52

 
55

Funding of mortgage loans
(58
)
 
(37
)
Proceeds from sales and collections of other investments
33

 
26

Purchase of other investments
(73
)
 
(46
)
Purchase of equipment and software
(2
)
 
(2
)
Change in policy loans, net
(2
)
 
7

Cash paid for deposit receivable
(1
)
 
(345
)
Cash received for deposit receivable
30

 

Advance on line of credit to Ameriprise Financial, Inc.
702

 

Repayment from Ameriprise Financial, Inc. on line of credit
(702
)
 

Cash received from written options with deferred premiums
95

 
34

Cash paid for written options with deferred premiums
(258
)
 
(42
)
Other, net
1

 
15

Net cash provided by (used in) investing activities
(43
)
 
(119
)
See Notes to Consolidated Financial Statements.

6



RIVERSOURCE LIFE INSURANCE COMPANY

 
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (continued)
 
 
 
Three Months Ended
March 31,
 
2020
 
2019
 
(in millions)
 
Cash Flows from Financing Activities
 
 
 
 
Policyholder account balances:
 
 
 
 
Deposits and other additions
$
255

 
$
585

 
Net transfers from (to) separate accounts
30

 
(1
)
 
Surrenders and other benefits
(430
)
 
(476
)
 
Proceeds from line of credit with Ameriprise Financial, Inc.
5

 

 
Payments on line of credit with Ameriprise Financial, Inc.
(55
)
 

 
Cash received for purchased options with deferred premiums

 
12

 
Cash paid for purchased options with deferred premiums
(36
)
 
(37
)
 
Cash dividends to Ameriprise Financial, Inc.
(250
)
 
(250
)
 
Net cash provided by (used in) financing activities
(481
)
 
(167
)
 
Net increase (decrease) in cash and cash equivalents
3,781

 
(109
)
 
Cash and cash equivalents at beginning of period
1,275

 
1,085

 
Cash and cash equivalents at end of period
$
5,056

 
$
976

 
 
 
 
 
 
Supplemental Disclosures:
 
 
 
 
Income taxes paid (received), net
$
2

 
$
(1
)
 
Interest paid on borrowings
1

 
1

 
Non-cash investing activity:
 

 
 

 
Partnership commitments not yet remitted
2

 

 
Investments transferred in connection with reinsurance transaction

 
1,265

 
See Notes to Consolidated Financial Statements.

7



RIVERSOURCE LIFE INSURANCE COMPANY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. Basis of Presentation
RiverSource Life Insurance Company is a stock life insurance company with one wholly owned stock life insurance company subsidiary, RiverSource Life Insurance Co. of New York (“RiverSource Life of NY”). RiverSource Life Insurance Company is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”).
RiverSource Life Insurance Company is domiciled in Minnesota and holds Certificates of Authority in American Samoa, the District of Columbia and all states except New York. RiverSource Life Insurance Company issues insurance and annuity products.
RiverSource Life of NY is domiciled and holds a Certificate of Authority in New York. RiverSource Life of NY issues insurance and annuity products.
RiverSource Life Insurance Company also wholly owns RiverSource Tax Advantaged Investments, Inc. (“RTA”). RTA is a stock company domiciled in Delaware and is a limited partner in affordable housing partnership investments.
The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation.
The interim financial information in this report has not been audited. In the opinion of management, all adjustments necessary for fair statement of the consolidated financial position and results of operations for the interim periods have been made. All adjustments made were of a normal recurring nature.
The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. These Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 26, 2020 (“2019 10-K”).
The Company evaluated events or transactions that may have occurred after the balance sheet date for potential recognition or disclosure through the date the financial statements were issued. No subsequent events or transactions were identified.
2. Summary of Significant Accounting Policies
The Company adopted accounting standard, Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments, on January 1, 2020. The significant accounting policies for Available-for-Sale Securities, Financing Receivables, and Reinsurance were updated as a result of adopting the new accounting standard. Refer to Note 3 for further details of the adoption.
Available-for-Sale Securities
Available-for-Sale securities are carried at fair value with unrealized gains (losses) recorded in accumulated other comprehensive income (“AOCI”), net of impacts to deferred acquisition costs (“DAC”), deferred sales inducement costs (“DSIC”), unearned revenue, benefit reserves, reinsurance recoverables and income taxes. Gains and losses are recognized on a trade date basis in the Consolidated Statements of Income upon disposition of the securities.
Available-for-Sale securities are impaired when the fair value of an investment is less than its amortized cost. When an Available-for-Sale security is impaired, the Company first assesses whether or not: (i) it has the intent to sell the security (made a decision to sell) or (ii) it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions exist, the Company recognizes an impairment by reducing the book value of the security for the difference between the investment’s amortized cost and its fair value with a corresponding charge to earnings. Subsequent increases in the fair value of Available-for-Sale securities that occur in periods after a write-down has occurred are recorded as unrealized gains in other comprehensive income (“OCI”), while subsequent decreases in fair value would continue to be recorded as reductions of book value with a charge to earnings.
For securities that do not meet the above criteria, the Company determines whether the decrease in fair value is due to a credit loss or due to other factors. The amount of impairment due to credit-related factors, if any, is recognized as an allowance for credit losses with a related charge to net realized investment gains (losses). The allowance for credit losses is limited to the amount by which the security’s amortized cost basis exceeds its fair value. The amount of the impairment related to other factors is recognized in OCI. Factors the Company considers in determining whether declines in the fair value of fixed maturity securities are due to credit-related factors include: (i) the extent to which the market value is below amortized cost; (ii) fundamental analysis of the liquidity, business prospects and overall financial condition of the issuer; and (iii) market events that could impact credit ratings, economic and business climate, litigation and government actions, and similar external business factors.
If through subsequent evaluation there is a sustained increase in cash flows expected, both the allowance and related charge to earnings may be reversed to reflect the increase in expected principal and interest payments. However, for Available-for-Sale securities that recognized an impairment prior to January 1, 2020 by reducing the book value of the security, the difference between the new amortized cost basis and the improved cash flows expected to be collected is accreted as interest income.

8



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

In order to determine the amount of the credit loss component for corporate debt securities, a best estimate of the present value of cash flows expected to be collected discounted at the security’s effective interest rate is compared to the amortized cost basis of the security. The significant inputs to cash flow projections consider potential debt restructuring terms, projected cash flows available to pay creditors and the Company’s position in the debtor’s overall capital structure. When assessing potential credit-related impairments for structured investments (e.g., residential mortgage backed securities, commercial mortgage backed securities and asset backed securities), the Company also considers credit-related factors such as overall deal structure and its position within the structure, quality of underlying collateral, delinquencies and defaults, loss severities, recoveries, prepayments and cumulative loss projections.
Management has elected to exclude accrued interest in its measurement of the allowance for credit losses for Available-for-Sale securities. Accrued interest on Available-for-sale securities is recorded as earned in accrued investment income on the Consolidated Balance Sheets. Available-for-Sale securities are placed on nonaccrual status when the accrued balance becomes 90 days past due or earlier based on management’s evaluation of the facts and circumstances of each security under review. At this time all previously accrued interest is reversed through net investment income.
Financing Receivables
Financing receivables are comprised of commercial loans, policy loans, and deposit receivables.
Commercial Loans
Commercial loans include commercial mortgage loans and syndicated loans and are recorded at amortized cost less the allowance for loan losses. Commercial mortgage loans are recorded within mortgage loans and syndicated loans are recorded within other investments on the Consolidated Balance Sheets. Commercial mortgage loans are loans on commercial properties that are originated by the Company. Syndicated loans represent the Company’s investment in loan syndications originated by unrelated third parties.
Interest income is accrued as earned on the unpaid principal balances of the loans. Interest income recognized on commercial mortgage loans and syndicated loans is recorded in net investment income on the Consolidated Statements of Income.
Policy Loans
Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, the Company does not record an allowance for credit losses.
Interest income is accrued as earned on the unpaid principal balances of the loans. Interest income recognized on policy loans is recorded in accrued investment income on the Consolidated Statements of Income.
Deposit Receivable
For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability related to insurance risk in accordance with applicable accounting standards. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Reinsurance deposits made are included in receivables. As amounts are received, consistent with the underlying contracts, the deposit receivable is adjusted. The deposit receivable is accreted using the interest method and the accretion is reported in other revenues.
See Note 7 for additional information on financing receivables.
Allowance for Credit Losses
The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected over the asset’s expected life, considering past events, current conditions and reasonable and supportable forecasts of future economic conditions. Prior to January 1, 2020, the allowance for credit losses was based on an incurred loss model that did not require estimating expected credit losses over the expected life of the asset. Estimates of expected credit losses consider both historical charge-off and recovery experience as well as management’s expectation of future charge-off and recovery levels. Expected losses related to risks other than credit risk are excluded from the allowance for credit losses. The allowance for credit losses is measured and recorded upon initial recognition of the loan, regardless of whether it is originated or purchased. The methods and information used to develop the allowance for credit losses for each class of financing receivable are discussed below.
Commercial Loans
The allowance for credit losses for commercial mortgage loans and syndicated loans utilizes a probability of default and loss severity approach to estimate lifetime expected credit losses. Actual historical default and loss severity data for each type of commercial loan is adjusted for current conditions and reasonable and supportable forecasts of future economic conditions to develop the probability of default and loss severity assumptions that are applied to the amortized cost basis of the loans over the expected life of each portfolio. The allowance for credit losses on commercial mortgage loans and syndicated loans is recorded through provisions charged to net realized investment gains (losses) and is reduced/increased by net charge-offs/recoveries.
Management determines the adequacy of the allowance for credit losses based on the overall loan portfolio composition, recent and historical loss experience, and other pertinent factors, including when applicable, internal risk ratings, loan-to-value (“LTV”) ratios

9



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

and occupancy rates, along with reasonable and supportable forecasts of economic and market conditions. This evaluation is inherently subjective as it requires estimates, which may be susceptible to significant change. While the Company may attribute portions of the allowance to specific loan pools as part of the allowance estimation process, the entire allowance is available to absorb losses expected over the life of the loan portfolio.
Deposit receivable
The allowance for credit losses is calculated on an individual reinsurer basis. The deposit receivable is collateralized by an underlying trust arrangement. Management evaluates the terms of the reinsurance and trust agreements, the nature of the underlying assets, and the potential for changes in the collateral value when considering the need for an allowance for credit losses.
Nonaccrual Loans
Commercial mortgage loans and syndicated loans are placed on nonaccrual status when either the collection of interest or principal has become 90 days past due or is otherwise considered doubtful of collection. When a loan is placed on nonaccrual status, unpaid accrued interest is reversed. Interest payments received on loans on nonaccrual status are generally applied to principal unless the remaining principal balance has been determined to be fully collectible. Management has elected to exclude accrued interest in its measurement of the allowance for credit losses for commercial mortgage loans and syndicated loans.
Restructured Loans
A loan is classified as a restructured loan when the Company makes certain concessionary modifications to contractual terms for borrowers experiencing financial difficulties. When the interest rate, minimum payments, and/or due dates have been modified in an attempt to make the loan more affordable to a borrower experiencing financial difficulties, the modification is considered a troubled debt restructuring. Generally, performance prior to the restructuring or significant events that coincide with the restructuring are considered in assessing whether the borrower can meet the new terms which may result in the loan being returned to accrual status at the time of the restructuring or after a performance period. If the borrower’s ability to meet the revised payment schedule is not reasonably assured, the loan remains on nonaccrual status.
Charge-off and Foreclosure
Charge-offs are recorded when the Company concludes that all or a portion of the commercial mortgage loan or syndicated loan is uncollectible. Factors used by the Company to determine whether all amounts due on commercial mortgage loans will be collected, include but are not limited to, the financial condition of the borrower, performance of the underlying properties, collateral and/or guarantees on the loan, and the borrower’s estimated future ability to pay based on property type and geographic location. Factors used by the Company to determine whether all amounts due on syndicated loans will be collected, include but are not limited to the borrower’s financial condition, industry outlook, and internal risk ratings based on rating agency data and internal analyst expectations.
If it is determined that foreclosure on a commercial mortgage loan is probable and the fair value is less than the current loan balance, expected credit losses are measured as the difference between the amortized cost basis of the asset and fair value less estimated selling costs. Upon foreclosure, the commercial mortgage loan and related allowance are reversed, and the foreclosed property is recorded as real estate owned in other assets.
Reinsurance
Policyholder account balances, future policy benefits and claims recoverable under reinsurance contracts are recorded within receivables, net of the allowance for credit losses. The Company evaluates the financial condition of its reinsurers prior to entering into new reinsurance contracts and on a periodic basis during the contract term. The allowance for credit losses related to reinsurance recoverable is based on applying observable industry data including insurer ratings, default and loss severity data to the Company’s reinsurance recoverable balances. Management evaluates the results of the calculation and considers differences between the industry data and the Company’s data. Such differences include the fact that the Company has no actual history of losses and the fact that industry data may contain non-life insurers. This evaluation is inherently subjective as it requires estimates, which may be susceptible to significant change given the long-term nature of these receivables. In addition, the Company has a reinsurance protection agreement that provides credit protections for its reinsured long term care business. The allowance for credit losses on reinsurance recoverable is recorded through provisions charged to benefits, claims, losses and settlement expenses on the Consolidated Statements of Income.
3. Recent Accounting Pronouncements
Adoption of New Accounting Standards
Fair Value Measurement – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement
In August 2018, the Financial Accounting Standards Board (“FASB”) updated the accounting standards related to disclosures for fair value measurements. The update eliminates the following disclosures: 1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, 2) the policy of timing of transfers between levels of the fair value hierarchy, and 3) the valuation processes for Level 3 fair value measurements. The new disclosures include changes in unrealized gains and losses for the period included in OCI for recurring Level 3 fair value measurements of instruments held at the end of the reporting period and the range and

10



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

weighted average used to develop significant unobservable inputs and how the weighted average was calculated. The new disclosures are required on a prospective basis; all other provisions should be applied retrospectively. The update is effective for interim and annual periods beginning after December 15, 2019. Early adoption is permitted for the entire standard or only the provisions to eliminate or modify disclosure requirements. The Company early adopted the provisions of the standard to eliminate or modify disclosure requirements in the fourth quarter of 2018. The Company adopted the provisions of the standard to include new disclosures on January 1, 2020. The update does not have an impact on the Company’s consolidated results of operations or financial condition. See Note 12 for additional disclosures on fair value measurements.
Intangibles – Goodwill and Other – Internal-Use Software – Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
In August 2018, the FASB updated the accounting standards related to customer’s accounting for implementation costs incurred in a cloud computing arrangement (“CCA”) that is a service contract. The update requires implementation costs for a CCA to be evaluated for capitalization using the same approach as implementation costs associated with internal-use software. The update also addresses presentation, measurement and impairment of capitalized implementation costs in a CCA that is a service contract. The update requires new disclosures on the nature of hosting arrangements that are service contracts, significant judgements made when applying the guidance and quantitative disclosures, including amounts capitalized, amortized and impaired. The update is effective for interim and annual periods beginning after December 15, 2019, and can be applied either prospectively or retrospectively. The Company adopted the standard using a prospective approach on January 1, 2020. The adoption did not have an impact on the Company’s consolidated financial condition or results of operations.
Financial Instruments – Credit Losses – Measurement of Credit Losses on Financial Instruments
In June 2016, the FASB updated the accounting standards related to accounting for credit losses on certain types of financial instruments. The update replaces the current incurred loss model for estimating credit losses with a new model that requires an entity to estimate the credit losses expected over the life of the asset. At adoption, the initial estimate of the expected credit losses will be recorded through retained earnings and subsequent changes in the estimate will be reported in current period earnings and recorded through an allowance for credit losses on the balance sheet. The credit loss model for Available-for-Sale debt securities did not change; however, the credit loss calculation and subsequent recoveries are required to be recorded through an allowance. The standard is effective for interim and annual periods beginning after December 15, 2019. A modified retrospective cumulative adjustment to retained earnings should be recorded as of the first reporting period in which the guidance is effective for loans, receivables, and other financial instruments subject to the new expected credit loss model. Prospective adoption is required for establishing an allowance related to Available-for-Sale debt securities, certain beneficial interests, and financial assets purchased with a more-than-insignificant amount of credit deterioration since origination. The Company adopted the standard on January 1, 2020. The adoption of this update did not have a material impact on the Company’s consolidated financial condition or results of operations.
Leases – Recognition of Lease Assets and Liabilities on Balance Sheet
In February 2016, the FASB updated the accounting standards for leases. The update was issued to increase transparency and comparability for the accounting of lease transactions. The standard requires most lease transactions for lessees to be recorded on the balance sheet as lease assets and lease liabilities and both quantitative and qualitative disclosures about leasing arrangements. The standard was effective for interim and annual periods beginning after December 15, 2018. Entities had the option to adopt the standard using a modified retrospective approach at either the beginning of the earliest period presented or as of the date of adoption. The Company adopted the standard using a modified retrospective approach as of January 1, 2019. The Company also elected the package of practical expedients permitted under the transition guidance within the accounting standard that allows entities to carryforward their historical lease classification and to not reassess contracts for embedded leases among other things. The adoption did not have a material impact on the Company’s consolidated financial condition or results of operations.
Income Statement – Reporting Comprehensive Income – Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
In February 2018, the FASB updated the accounting standards related to the presentation of tax effects stranded in AOCI. The update allows a reclassification from AOCI to retained earnings for tax effects stranded in AOCI resulting from the legislation commonly referred to as the Tax Cuts and Jobs Act (“Tax Act”). The election of the update was optional. The update was effective for fiscal years beginning after December 15, 2018. Entities could record the impacts either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Act is recognized. The Company adopted the standard on January 1, 2019 and elected not to reclassify the stranded tax effects in AOCI.
Derivatives and Hedging – Targeted Improvements to Accounting for Hedging Activities
In August 2017, the FASB updated the accounting standards to amend the hedge accounting recognition and presentation requirements. The objectives of the update are to better align the financial reporting of hedging relationships to the economic results of an entity’s risk management activities and simplify the application of the hedge accounting guidance. The update also adds new disclosures and amends existing disclosure requirements. The standard was effective for interim and annual periods beginning after December 15, 2018, and was required to be applied on a modified retrospective basis. The Company adopted the standard on January 1, 2019. The adoption did not have an impact on the Company’s consolidated financial condition or results of operations.

11



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Receivables – Nonrefundable Fees and Other Costs – Premium Amortization on Purchased Callable Debt Securities
In March 2017, the FASB updated the accounting standards to shorten the amortization period for certain purchased callable debt securities held at a premium. Under previous guidance, premiums were generally amortized over the contractual life of the security. The amendments require the premium to be amortized to the earliest call date. The update applies to securities with explicit, non-contingent call features that are callable at fixed prices and on preset dates. The standard was effective for interim and annual periods beginning after December 15, 2018, and was required to be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted the standard on January 1, 2019. The adoption did not have a material impact on the Company’s consolidated financial condition or results of operations.
Future Adoption of New Accounting Standards
Reference Rate Reform – Expedients for Contract Modifications
In March 2020, the FASB updated the accounting standards to provide optional  expedients and exceptions for applying GAAP to contracts, hedging or other transactions that are affected by reference rate reform (i.e., the elimination of LIBOR). The following expedients are provided for modified contracts whose reference rate is changed: 1) receivables and debt contracts are accounted for prospectively by adjusting the effective interest rate, 2)  leases are accounted for as a continuation of the existing contracts with no reassessments of the lease classification and discount rate or remeasurements of lease payments that otherwise would be required, and 3) an entity is not required to reassess its original conclusion about whether that contract contains an embedded derivative that is clearly and closely related to the economic characteristics and risks of the host contract. When elected, the optional expedients for contract modifications must be applied consistently for all eligible contracts or eligible transactions. The Company is currently evaluating the impact of electing to adopt the standard on its consolidated financial condition and results of operations.
Income Taxes – Simplifying the Accounting for Income Taxes
In December 2019, the FASB updated the accounting standards to simplify the accounting for income taxes. The update eliminates certain exceptions to accounting principles related to intraperiod tax allocation (prospective basis), deferred tax liabilities related to outside basis differences (modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption) and year-to-date losses in interim periods (prospective basis). The update also amends existing guidance related to situations when an entity receives a step-up in the tax basis of goodwill (prospective basis), allocation of income tax expense when members of a consolidated tax filing group issue separate financial statements (retrospective basis for all periods presented), interim recognition of enactment of tax laws or rate changes (prospective basis) and franchise taxes and other taxes partially based on income (retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption). The standard is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The method of adoption is noted parenthetically after each amendment above. The Company is currently evaluating the impact of the standard on its consolidated financial condition or results of operations.
Financial Services – Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts
In August 2018, the FASB updated the accounting standard related to long-duration insurance contracts. The guidance revises key elements of the measurement models and disclosure requirements for long-duration insurance contracts issued by insurers and reinsurers.
The guidance establishes a significant new category of benefit features called market risk benefits that protect the contractholder from other-than-nominal capital market risk and expose the insurer to that risk. Insurers will have to measure market risk benefits at fair value. Market risk benefits include variable annuity guaranteed benefits (i.e. guaranteed minimum death, withdrawal, withdrawal for life, accumulation and income benefits). The portion of the change in fair value attributable to a change in the instrument-specific credit risk of market risk benefits in a liability position will be recorded in OCI.
Significant changes also relate to the measurement of the liability for future policy benefits for nonparticipating traditional long-duration insurance contracts and immediate annuities with a life contingent feature include the following:
Insurers will be required to review and update the cash flow assumptions used to measure the liability for future policy benefits rather than using assumptions locked in at contract inception. The review of assumptions to measure the liability for all future policy benefits will be required annually at the same time each year, or more frequently if suggested by experience. The effect of updating assumptions will be measured on a retrospective catch-up basis and presented separate from the ongoing policyholder benefit expense in the statement of operations in the period the update is made. This new unlocking process will be required for the Company’s term and whole life insurance, disability income, long term care insurance and immediate annuities with a life contingent feature.
The discount rate used to measure the liability for future policy benefits will be standardized. The current requirement to use a discount rate reflecting expected investment yields will change to an upper-medium grade (low credit risk) fixed income corporate instrument yield (generally interpreted as an “A” rating) reflecting the duration characteristics of the liability. Entities will be required to update the discount rate at each reporting date with the effect of discount rate changes reflected in OCI.

12



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The current premium deficiency test is being replaced with a net premium ratio cap of 100%. If the net premium ratio (i.e. the ratio of the present value of total expected benefits and related expenses to the present value of total expected premiums) exceeds 100%, insurers are required to recognize a loss in the statement of operations in the period. Contracts from different issue years will no longer be permitted to be grouped to determine contracts in a loss position.
In addition, the update requires DAC and DSIC relating to all long-duration contracts and most investment contracts to be amortized on a straight-line basis over the expected life of the contract independent of profit emergence. Under the new guidance, interest will not accrue to the deferred balance and DAC and DSIC will not be subject to an impairment test.
The update requires significant additional disclosures, including disaggregated rollforwards of the liability for future policy benefits, policyholder account balances, market risk benefits, DAC and DSIC, as well as qualitative and quantitative information about expected cash flows, estimates and assumptions. The update is currently effective for interim and annual periods beginning after December 15, 2021. The standard should be applied to the liability for future policy benefits and DAC and DSIC on a modified retrospective basis and applied to market risk benefits on a retrospective basis with the option to apply full retrospective transition if certain criteria are met. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial condition, results of operations and disclosures.
4. Revenue from Contracts with Customers
The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Consolidated Statements of Income.
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Policy and contract charges
 
 
 
   Affiliated
$
41

 
$
41

   Unaffiliated
3

 
4

Total
44

 
45

 
 
 
 
Other revenues
 
 
 
   Administrative fees
 
 
 
      Affiliated
11

 
10

      Unaffiliated
4

 
4

 
15

 
14

   Other fees
 
 
 
      Affiliated
86

 
83

      Unaffiliated
1

 
1

 
87

 
84

Total
102

 
98

Total revenue from contracts with customers
146

 
143

Revenue from other sources (1)
823

 
801

Total revenues
$
969

 
$
944

(1) Amounts primarily consist of revenue associated with insurance and annuity products or financial instruments.
The following discussion describes the nature, timing, and uncertainty of revenues and cash flows arising from the Company’s contracts with customers.
Policy and contract charges
The Company earns revenue for providing distribution-related services to affiliated and unaffiliated mutual funds that are available as underlying investments in its variable annuity and variable life insurance products. The performance obligation is satisfied at the time the mutual fund is distributed. Revenue is recognized over the time the mutual fund is held in the variable product and is generally earned based on a fixed rate applied, as a percentage, to the net asset value of the fund. The revenue is not recognized at the time of sale because it is variably constrained due to factors outside the Company’s control, including market volatility and how long the fund(s) remain in the insurance policy or annuity contract. The revenue will not be recognized until it is probable that a significant reversal will not occur. These fees are accrued and collected on a monthly basis.

13



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Other revenues
Administrative fees
The Company earns revenue for providing customer support, contract servicing and administrative services for affiliated and unaffiliated mutual funds that are available as underlying instruments in its variable annuity and variable life insurance products. The transfer agent and administration revenue is earned daily based on a fixed rate applied, as a percentage, to assets under management. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.
Other fees
The Company earns revenue for providing affiliated and unaffiliated partners an opportunity to educate the financial advisors of its affiliate, Ameriprise Financial Services, Inc., that sell the Company's products as well as product and marketing personnel to support the offer, sale and servicing of funds within the Company's variable annuity and variable life insurance products. These payments allow the parties to train and support the advisors, explain the features of their products, and distribute marketing and educational materials. The affiliated revenue is earned based on a rate, updated at least annually, which is applied, as a percentage, to the market value of assets invested. The unaffiliated revenue is earned based on a fixed rate applied, as a percentage, to the market value of assets invested. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.
Receivables
Receivables for revenue from contracts with customers are recognized when the performance obligation is satisfied and the Company has an unconditional right to the revenue. Receivables related to revenues from contracts with customers were $49 million and $55 million as of March 31, 2020 and December 31, 2019, respectively.
5. Variable Interest Entities
The Company is a limited partner in affordable housing partnerships that qualify for government-sponsored low income housing tax credit programs and partnerships that invest in multi-family residential properties that were originally developed with an affordable housing component. The Company has determined it is not the primary beneficiary and therefore does not consolidate these partnerships.
A majority of the limited partnerships are variable interest entities (“VIEs”). The Company’s maximum exposure to loss as a result of its investment in the VIEs is limited to the carrying value. The carrying value is reflected in other investments and was $255 million and $270 million as of March 31, 2020 and December 31, 2019, respectively. The Company had a $12 million and a $15 million liability recorded as of March 31, 2020 and December 31, 2019, respectively, related to original purchase commitments not yet remitted to the VIEs. The Company has not provided any additional support and is not contractually obligated to provide additional support to the VIEs beyond the funding commitments.
The Company invests in structured investments which are considered VIEs for which it is not generally the sponsor. These structured investments typically invest in fixed income instruments and are primarily managed by third parties and include asset backed securities, commercial and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the lack of power to direct the activities that most significantly impact the economic performance, size of the Company’s investment in the entities and position in the capital structure of these entities. The Company’s maximum exposure to loss as a result of its investment in these structured investments is limited to its amortized cost. The Company has no obligation to provide financial or other support to the structured investments beyond its investment nor has the Company provided any support to the structured investments. See Note 6 for additional information on these structured investments.

14



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

6. Investments
Available-for-Sale securities distributed by type were as follows:
Description of Securities
 
March 31, 2020
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Allowance for Credit Losses
 
Fair Value
 
 
(in millions)
Fixed maturities:
 
 

 
 

 
 

 
 

 
 

Corporate debt securities
 
$
9,934

 
$
850

 
$
(328
)
 
$
(13
)
 
$
10,443

Residential mortgage backed securities
 
3,107

 
96

 
(25
)
 

 
3,178

Commercial mortgage backed securities
 
3,613

 
59

 
(34
)
 

 
3,638

State and municipal obligations
 
1,044

 
233

 
(5
)
 

 
1,272

Asset backed securities
 
1,029

 
25

 
(91
)
 

 
963

Foreign government bonds and obligations
 
246

 
9

 
(8
)
 

 
247

U.S. government and agency obligations
 
1

 

 

 

 
1

Total
 
$
18,974

 
$
1,272

 
$
(491
)
 
$
(13
)
 
$
19,742

Description of Securities
 
December 31, 2019
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
 
 
(in millions)
Fixed maturities:
 
 

 
 

 
 

 
 

Corporate debt securities
 
$
10,188

 
$
1,336

 
$
(2
)
 
$
11,522

Residential mortgage backed securities
 
3,039

 
73

 
(4
)
 
3,108

Commercial mortgage backed securities
 
3,526

 
95

 
(3
)
 
3,618

State and municipal obligations
 
1,071

 
237

 
(2
)
 
1,306

Asset backed securities
 
1,036

 
45

 
(1
)
 
1,080

Foreign government bonds and obligations
 
250

 
19

 
(2
)
 
267

U.S. government and agency obligations
 
1

 

 

 
1

Total
 
$
19,111

 
$
1,805

 
$
(14
)
 
$
20,902


In March 2020, the Company purchased $368 million of investments at fair value, primarily agency residential mortgage back securities, from Ameriprise Financial.
As of March 31, 2020 and December 31, 2019, accrued interest of $164 million and $158 million, respectively, is excluded from the amortized cost basis of Available-for-Sale securities in the tables above and is recorded in accrued investment income on the Consolidated Balance Sheets.
As of March 31, 2020 and December 31, 2019, investment securities with a fair value of $2.1 billion and $1.9 billion, respectively, were pledged to meet contractual obligations under derivative contracts and short-term borrowings, of which $411 million and $576 million, respectively, may be sold, pledged or rehypothecated by the counterparty.
As of March 31, 2020 and December 31, 2019, fixed maturity securities comprised approximately 82% and 83%, respectively, of the Company’s total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of March 31, 2020 and December 31, 2019, approximately $549 million and $615 million, respectively, of securities were internally rated by Columbia Management Investment Advisers, LLC, an affiliate of the Company, using criteria similar to those used by NRSROs.

15



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

A summary of fixed maturity securities by rating was as follows:
Ratings
 
March 31, 2020
 
December 31, 2019
Amortized Cost
 
Fair Value
 
Percent of Total Fair Value
Amortized Cost
 
Fair Value
 
Percent of Total Fair Value
 
 
(in millions, except percentages)
 
 
AAA
 
$
7,027

 
$
7,138

 
36
%
 
$
6,771

 
$
6,950

 
33
%
AA
 
1,072

 
1,181

 
6

 
1,176

 
1,374

 
7

A
 
2,657

 
3,085

 
16

 
2,695

 
3,157

 
15

BBB
 
7,099

 
7,365

 
37

 
7,709

 
8,626

 
41

Below investment grade
 
1,119

 
973

 
5

 
760

 
795

 
4

Total fixed maturities
 
$
18,974

 
$
19,742

 
100
%
 
$
19,111

 
$
20,902

 
100
%

As of March 31, 2020 and December 31, 2019, approximately 42% and 39%, respectively, of securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities. The Company had no holdings which were greater than 10% of total equity as of March 31, 2020. The Company had holdings of $380 million in Ameriprise Advisor Financing, LLC (“AAF”), an affiliate of the Company, which was greater than 10% of total equity as of December 31, 2019. There were no other holdings of any other issuer greater than 10% of total equity as of December 31, 2019.
The following tables provide information about Available-for-Sale securities with gross unrealized losses and the length of time that individual securities have been in a continuous unrealized loss position:
Description of Securities 
March 31, 2020
Less than 12 months
 
12 months or more
 
Total
Number of Securities
 
Fair Value
 
Unrealized Losses (1)
Number of Securities
 
Fair Value
 
Unrealized Losses (1)
Number of Securities
 
Fair Value
 
Unrealized Losses (1)
 
(in millions, except number of securities)
Corporate debt securities
183

 
$
2,425

 
$
(332
)
 
3

 
$
13

 
$
(9
)
 
186

 
$
2,438

 
$
(341
)
Residential mortgage backed securities
88

 
1,174

 
(24
)
 
7

 
8

 
(1
)
 
95

 
1,182

 
(25
)
Commercial mortgage backed securities
62

 
1,305

 
(34
)
 
1

 

 

 
63

 
1,305

 
(34
)
State and municipal obligations
5

 
79

 
(4
)
 
1

 
4

 
(1
)
 
6

 
83

 
(5
)
Asset backed securities
28

 
550

 
(90
)
 
2

 
23

 
(1
)
 
30

 
573

 
(91
)
Foreign government bonds and obligations
18

 
89

 
(6
)
 
8

 
10

 
(2
)
 
26

 
99

 
(8
)
Total
384

 
$
5,622

 
$
(490
)
 
22

 
$
58

 
$
(14
)
 
406

 
$
5,680

 
$
(504
)
(1) Unrealized losses of $13 million due to credit-related factors is recorded in the allowance for credit losses as of March 31, 2020.
Description of Securities 
December 31, 2019
Less than 12 months
 
12 months or more
 
Total
Number of Securities
 
Fair Value
 
Unrealized Losses
Number of Securities
 
Fair Value
 
Unrealized Losses
Number of Securities
 
Fair Value
 
Unrealized Losses
 
(in millions, except number of securities)
Corporate debt securities
15

 
$
64

 
$

 
7

 
$
90

 
$
(2
)
 
22

 
$
154

 
$
(2
)
Residential mortgage backed securities
29

 
571

 
(1
)
 
20

 
298

 
(3
)
 
49

 
869

 
(4
)
Commercial mortgage backed securities
18

 
310

 
(1
)
 
7

 
82

 
(2
)
 
25

 
392

 
(3
)
State and municipal obligations
5

 
23

 

 
3

 
54

 
(2
)
 
8

 
77

 
(2
)
Asset backed securities
10

 
111

 
(1
)
 
6

 
54

 

 
16

 
165

 
(1
)
Foreign government bonds and obligations
1

 

 

 
10

 
15

 
(2
)
 
11

 
15

 
(2
)
Total
78

 
$
1,079

 
$
(3
)
 
53

 
$
593

 
$
(11
)
 
131

 
$
1,672

 
$
(14
)


16



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

As part of the Company’s ongoing monitoring process, management determined that the change in gross unrealized losses on its Available-for-Sale securities during the first quarter of 2020 is attributable to wider credit spreads, partially offset by lower interest rates.
The following table presents a rollforward of the allowance for credit losses on Available-for-Sale securities by type:
 
Corporate Debt Securities
(in millions)
Balance, January 1, 2020 (1)
$

Additions for which credit losses were not previously recognized
13

Balance, March 31, 2020
$
13

(1) Prior to January 1, 2020, credit losses on Available-for-Sale securities were not recorded in an allowance but were recorded as a reduction of the book value of the security if the security was other-than-temporarily impaired. There is no adoption impact due to the prospective transition for Available-for-Sale securities.
Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains (losses) were as follows:
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Gross realized investment gains
$
6

 
$
19

Gross realized investment losses
(1
)
 
(9
)
Credit losses
(13
)
 

Total
$
(8
)
 
$
10


Credit losses for the three months ended March 31, 2020 primarily related to recording an allowance for credit losses on certain corporate debt securities, primarily in the oil and gas industry.
See Note 15 for a rollforward of net unrealized investment gains (losses) included in AOCI.
Available-for-Sale securities by contractual maturity as of March 31, 2020 were as follows:
 
Amortized Cost
 
Fair Value
(in millions)
Due within one year
$
620

 
$
622

Due after one year through five years
4,170

 
4,163

Due after five years through 10 years
2,471

 
2,553

Due after 10 years
3,964

 
4,625

 
11,225

 
11,963

Residential mortgage backed securities
3,107

 
3,178

Commercial mortgage backed securities
3,613

 
3,638

Asset backed securities
1,029

 
963

Total
$
18,974

 
$
19,742


Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities were not included in the maturities distribution.

17



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The following is a summary of net investment income:
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Fixed maturities
$
201

 
$
229

Mortgage loans
29

 
29

Other investments
(1
)
 
4

 
229

 
262

Less: investment expenses
6

 
6

Total
$
223

 
$
256


7. Financing Receivables
Financing receivables are comprised of commercial loans, policy loans, and the deposit receivable. See Note 2 for information regarding the Company’s accounting policies related to financing receivables and the allowance for credit losses.
Allowance for Credit Losses
The following tables present a rollforward of the allowance for credit losses for the three months ended March 31:
 
Commercial Loans
(in millions)
Balance, December 31, 2019 (1)
$
20

Cumulative effect of adoption of current expected credit losses guidance
3

Balance, January 1, 2020
23

Provisions
9

Balance, March 31, 2020
$
32

(1) Prior to January 1, 2020, the allowance for credit losses was based on an incurred loss model that did not require estimating expected credit losses over the expected life of the asset.
 
Commercial Loans
(in millions)
Balance, January 1, 2019
$
20

Write-offs

Balance, March 31, 2019
$
20


As of both March 31, 2020 and December 31, 2019, accrued interest on commercial loans was $11 million and is recorded in accrued investment income on the Consolidated Balance Sheets and excluded from the amortized cost basis of commercial loans.
Purchases and Sales
During the three months ended March 31, 2020 and 2019, the Company purchased $41 million and $25 million, respectively, of syndicated loans and sold $7 million and $9 million, respectively, of syndicated loans.
The Company has not acquired any loans with deteriorated credit quality as of the acquisition date.
Credit Quality Information
Nonperforming loans were $12 million and $9 million as of March 31, 2020 and December 31, 2019, respectively. All other loans were considered to be performing.
Commercial Loans
Commercial Mortgage Loans
The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on commercial mortgage loans. Loan-to-value ratio is the primary credit quality indicator included in this review. Total commercial mortgage loans past due were nil as of both March 31, 2020 and December 31, 2019.
Based on this review, the commercial mortgage loans are assigned an internal risk rating, which management updates as necessary. Commercial mortgage loans which management has assigned its highest risk rating were less than 1% of total commercial mortgage

18



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

loans as of both March 31, 2020 and December 31, 2019. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months.
The table below presents the amortized cost basis of commercial mortgage loans as of March 31, 2020 by year of origination and loan-to-value ratio:
Loan-to-Value Ratio
 
2020
 
2019
 
2018
 
2017
 
2016
 
Prior
 
Total
 
(in millions)
> 100%
 
$

 
$

 
$

 
$

 
$
1

 
$
11

 
$
12

80% - 100%
 
12

 
16

 
6

 
4

 
14

 
13

 
65

60% - 80%
 
29

 
168

 
85

 
41

 
61

 
122

 
506

40% - 60%
 
8

 
39

 
46

 
148

 
85

 
683

 
1,009

< 40%
 
5

 
22

 
48

 
82

 
69

 
860

 
1,086

Total
 
$
54

 
$
245

 
$
185

 
$
275

 
$
230

 
$
1,689

 
$
2,678


In addition, the Company reviews the concentrations of credit risk by region and property type. Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows:
 
Loans
 
Percentage
March 31,
2020
 
December 31,
2019
 
March 31,
2020
 
December 31,
2019
(in millions)
 
 
 
 
South Atlantic
$
712

 
$
705

 
27
%
 
26
%
Pacific
800

 
792

 
30

 
30

Mountain
234

 
237

 
9

 
9

West North Central
204

 
207

 
8

 
8

East North Central
228

 
232

 
8

 
9

Middle Atlantic
169

 
167

 
6

 
6

West South Central
167

 
169

 
6

 
6

New England
49

 
47

 
2

 
2

East South Central
115

 
116

 
4

 
4

 
2,678

 
2,672

 
100
%
 
100
%
Less: allowance for credit losses
25

 
17

 
 

 
 

Total
$
2,653

 
$
2,655

 
 

 
 


Concentrations of credit risk of commercial mortgage loans by property type were as follows:
 
Loans
 
Percentage
March 31,
2020
 
December 31,
2019
 
March 31,
2020
 
December 31,
2019
(in millions)
 
 
 
 
Retail
$
879

 
$
891

 
33
%

33
%
Office
392

 
404

 
14

 
15

Apartments
673

 
660

 
25

 
25

Industrial
402

 
404

 
15

 
15

Mixed use
78

 
66

 
3

 
3

Hotel
50

 
51

 
2

 
2

Other
204

 
196

 
8

 
7

 
2,678

 
2,672

 
100
%
 
100
%
Less: allowance for credit losses
25

 
17

 
 

 
 

Total
$
2,653

 
$
2,655

 
 

 
 



19



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Syndicated Loans
The recorded investment in syndicated loans as of March 31, 2020 and December 31, 2019 was $406 million and $395 million, respectively. The Company’s syndicated loan portfolio is diversified across industries and issuers, with limited exposure to the oil and gas industry. Total syndicated loans past due were nil and $1 million as of March 31, 2020 and December 31, 2019, respectively. The Company assigns an internal risk rating to each syndicated loan in its portfolio ranging from 1 through 5, with 5 reflecting the lowest quality.
The table below presents the amortized cost basis of syndicated loans as of March 31, 2020 by origination year and internal risk rating:
Internal Risk Rating
 
2020
 
2019
 
2018
 
2017
 
2016
 
Prior
 
Total
 
(in millions)
Risk 5
 
$

 
$

 
$

 
$

 
$

 
$

 
$

Risk 4
 

 
10

 
4

 
5

 
1

 
5

 
25

Risk 3
 

 
3

 
10

 
23

 
8

 
14

 
58

Risk 2
 
8

 
29

 
42

 
42

 
17

 
42

 
180

Risk 1
 
7

 
19

 
36

 
42

 
13

 
26

 
143

Total
 
$
15

 
$
61

 
$
92

 
$
112

 
$
39

 
$
87

 
$
406


Policy Loans
Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, the Company does not record an allowance for credit losses.
Deposit Receivable
The deposit receivable was $1.5 billion as of both March 31, 2020 and December 31, 2019. The deposit receivable is fully collateralized by the fair value of the assets held in a trust. Based on management’s evaluation of the nature of the underlying assets and the potential for changes in the collateral value, the Company did not have an allowance for credit losses for the deposit receivable as of both March 31, 2020 and December 31, 2019.
Troubled Debt Restructurings
There were no loans restructured by the Company during both the three months ended March 31, 2020 and 2019. There are no commitments to lend additional funds to borrowers whose loans have been restructured. 
8. Deferred Acquisition Costs and Deferred Sales Inducement Costs
The balances of and changes in DAC were as follows:
 
2020
 
2019
(in millions)
Balance at January 1
$
2,673

 
$
2,742

Capitalization of acquisition costs
57

 
54

Amortization
(503
)
 
(2
)
Impact of change in net unrealized (gains) losses on securities
118

 
(59
)
Balance at March 31
$
2,345

 
$
2,735


The balances of and changes in DSIC, which is included in other assets, were as follows:
 
2020
 
2019
(in millions)
Balance at January 1
$
216

 
$
249

Amortization
(36
)
 

Impact of change in net unrealized (gains) losses on securities
15

 
(10
)
Balance at March 31
$
195

 
$
239



20



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

9. Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities
Policyholder account balances, future policy benefits and claims consisted of the following:
 
March 31,
2020
 
December 31,
2019
(in millions)
Policyholder account balances
 
 
 
Fixed annuities (1)
$
8,774

 
$
8,909

Variable annuity fixed sub-accounts
5,126

 
5,103

UL/VUL insurance
3,125

 
3,110

Indexed universal life (“IUL”) insurance
2,086

 
2,025

Other life insurance
636

 
646

Total policyholder account balances
19,747

 
19,793

 
 
 
 
Future policy benefits
 
 
 
Variable annuity guaranteed minimum withdrawal benefits (“GMWB”)
3,899

 
1,462

Variable annuity guaranteed minimum accumulation benefits (“GMAB”) (2)
88

 
(39
)
Other annuity liabilities
154

 
139

Fixed annuity life contingent liabilities
1,432

 
1,444

Life and disability income insurance
1,199

 
1,212

Long term care insurance
5,125

 
5,302

UL/VUL and other life insurance additional liabilities
836

 
1,033

Total future policy benefits
12,733

 
10,553

Policy claims and other policyholders’ funds
197

 
158

Total policyholder account balances, future policy benefits and claims
$
32,677

 
$
30,504


(1) 
Includes fixed deferred annuities, non-life contingent fixed payout annuities and fixed deferred indexed annuity host contracts.
(2) 
Includes the fair value of GMAB embedded derivatives that was a net asset as of December 31, 2019 reported as a contra liability.
Separate account liabilities consisted of the following:
 
March 31,
2020
 
December 31,
2019
(in millions)
Variable annuity
$
64,744

 
$
74,965

VUL insurance
6,073

 
7,429

Other insurance
25

 
31

Total
$
70,842

 
$
82,425


10. Variable Annuity and Insurance Guarantees
The majority of the variable annuity contracts offered by the Company contain guaranteed minimum death benefit (“GMDB”) provisions. The Company also offers variable annuities with death benefit provisions that gross up the amount payable by a certain percentage of contract earnings, which are referred to as gain gross-up (“GGU”) benefits. In addition, the Company offers contracts with GMWB and GMAB provisions. The Company previously offered contracts containing guaranteed minimum income benefit (“GMIB”) provisions.
Certain UL policies offered by the Company provide secondary guarantee benefits. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges.

21



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities:
Variable Annuity
Guarantees by Benefit Type (1)
March 31, 2020
 
December 31, 2019
Total Contract Value
 
Contract Value in Separate Accounts
 
Net Amount at Risk
 
Weighted Average Attained Age
Total Contract Value
 
Contract Value in Separate Accounts
 
Net Amount at Risk
 
Weighted Average Attained Age
 
(in millions, except age)
GMDB:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Return of premium
$
55,082

 
$
53,129

 
$
611

 
68
 
$
62,909

 
$
60,967

 
$
5

 
67
Five/six-year reset
6,920

 
4,189

 
205

 
68
 
7,983

 
5,263

 
7

 
67
One-year ratchet
5,080

 
4,740

 
518

 
70
 
5,935

 
5,600

 
7

 
70
Five-year ratchet
1,195

 
1,139

 
46

 
67
 
1,396

 
1,340

 

 
66
Other
1,040

 
1,022

 
185

 
73
 
1,192

 
1,174

 
65

 
73
Total — GMDB
$
69,317

 
$
64,219

 
$
1,565

 
68
 
$
79,415

 
$
74,344

 
$
84

 
67
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GGU death benefit
$
955

 
$
899

 
$
107

 
71
 
$
1,115

 
$
1,063

 
$
133

 
71
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GMIB
$
150

 
$
136

 
$
18

 
70
 
$
186

 
$
172

 
$
6

 
70
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GMWB:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GMWB
$
1,691

 
$
1,685

 
$
6

 
73
 
$
1,999

 
$
1,993

 
$
1

 
73
GMWB for life
41,357

 
41,254

 
1,230

 
68
 
46,799

 
46,691

 
272

 
68
Total — GMWB
$
43,048

 
$
42,939

 
$
1,236

 
68
 
$
48,798

 
$
48,684

 
$
273

 
68
 
 
 
 
 
 
 
 
 
 
 
GMAB
$
2,184

 
$
2,181

 
$
35

 
60
 
$
2,528

 
$
2,524

 
$

 
60
(1) 
Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table.
The net amount at risk for GMDB, GGU and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero.
The following table provides information related to insurance guarantees for which the Company has established additional liabilities:
 
March 31, 2020
 
December 31, 2019
Net Amount at Risk
 
Weighted Average Attained Age
Net Amount at Risk
 
Weighted Average Attained Age
(in millions, except age)
UL secondary guarantees
$
6,550

 
67
 
$
6,550

 
67

The net amount at risk for UL secondary guarantees is defined as the current guaranteed death benefit amount in excess of the current policyholder account balance.

22



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows:
 
GMDB & GGU
 
GMIB
 
GMWB (1)
 
GMAB (1)
 
UL
(in millions)
Balance at January 1, 2019
$
19

 
$
8

 
$
875

 
$
(19
)
 
$
659

Incurred claims

 
(1
)
 
(104
)
 
(26
)
 
34

Paid claims
(2
)
 

 

 

 
(17
)
Balance at March 31, 2019
$
17

 
$
7

 
$
771

 
$
(45
)
 
$
676

 
 
 
 
 
 
 
 
 
 
Balance at January 1, 2020
$
16

 
$
7

 
$
1,462

 
$
(39
)
 
$
758

Incurred claims
5

 
2

 
2,437

 
127

 
32

Paid claims
(2
)
 

 

 

 
(12
)
Balance at March 31, 2020
$
19

 
$
9

 
$
3,899

 
$
88

 
$
778


(1) 
The incurred claims for GMWB and GMAB include the change in the fair value of the liabilities (contra liabilities) less paid claims.
The liabilities for guaranteed benefits are supported by general account assets.
The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits:
 
March 31,
2020
 
December 31,
2019
(in millions)
Mutual funds:
 

 
 

Equity
$
37,834

 
$
44,739

Bond
20,701

 
23,374

Other
5,888

 
6,471

Total mutual funds
$
64,423

 
$
74,584


11. Short-term Borrowings
RiverSource Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Des Moines which provides access to collateralized borrowings. The Company has pledged Available-for-Sale securities consisting of commercial mortgage backed securities to collateralize its obligation under these borrowings. The fair value of the securities pledged is recorded in investments and was $930 million and $840 million as of March 31, 2020 and December 31, 2019, respectively. The amount of the Company’s liability including accrued interest as of March 31, 2020 and December 31, 2019 was $200 million and $201 million, respectively. The remaining maturity of outstanding FHLB advances was less than three months as of March 31, 2020 and less than two months as of December 31, 2019. The weighted average annualized interest rate on the FHLB advances held as of March 31, 2020 and December 31, 2019 was 1.4% and 1.8%, respectively.
12. Fair Values of Assets and Liabilities
GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale.
Valuation Hierarchy
The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
Level 1
Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.
Level 2
Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.
Level 3
Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

23



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The following tables present the balances of assets and liabilities measured at fair value on a recurring basis:
 
March 31, 2020
 
Level 1
 
Level 2
 
Level 3
 
Total
(in millions)
Assets
 

 
 

 
 

 
 

 
Available-for-Sale securities:
 

 
 

 
 

 
 

 
Corporate debt securities
$

 
$
9,722

 
$
721

 
$
10,443

 
Residential mortgage backed securities

 
3,161

 
17

 
3,178

 
Commercial mortgage backed securities

 
3,638

 

 
3,638

 
State and municipal obligations

 
1,272

 

 
1,272

 
Asset backed securities

 
663

 
300

 
963

 
Foreign government bonds and obligations

 
247

 

 
247

 
U.S. government and agency obligations
1

 

 

 
1

 
Total Available-for-Sale securities
1

 
18,703

 
1,038

 
19,742

 
Cash equivalents
1,920

 
3,100

 

 
5,020

 
Other assets:
 
 
 
 
 
 
 

 
Interest rate derivative contracts
1

 
3,096

 

 
3,097

 
Equity derivative contracts
661

 
1,882

 

 
2,543

 
Foreign exchange derivative contracts

 
37

 

 
37

 
Credit derivative contracts

 
13

 

 
13

 
Total other assets
662


5,028

 

 
5,690

 
Separate account assets at net asset value (“NAV”)
 
 
 
 
 
 
70,842

(1) 
Total assets at fair value
$
2,583

 
$
26,831

 
$
1,038

 
$
101,294

 

Liabilities
 

 
 

 
 

 
 

 
Policyholder account balances, future policy benefits and claims:
 

 
 

 
 

 
 

 
Fixed deferred indexed annuity embedded derivatives
$

 
$
2

 
$
33

 
$
35

 
IUL embedded derivatives

 

 
725

 
725

 
GMWB and GMAB embedded derivatives

 

 
3,276

 
3,276

(2) 
Structured annuity embedded derivatives

 

 
(9
)
 
(9
)
 
Total policyholder account balances, future policy benefits and claims

 
2

 
4,025

 
4,027

(3) 
Other liabilities:
 

 
 

 
 

 
 

 
Interest rate derivative contracts

 
1,238

 

 
1,238

 
Equity derivative contracts
293

 
1,864

 

 
2,157

 
Foreign exchange derivative contracts
3

 
11

 

 
14

 
Total other liabilities
296

 
3,113

 

 
3,409

 
Total liabilities at fair value
$
296

 
$
3,115

 
$
4,025

 
$
7,436

 


24



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

 
December 31, 2019
 
Level 1
 
Level 2
 
Level 3
 
Total
(in millions)
Assets
 

 
 

 
 

 
 

 
Available-for-Sale securities:
 

 
 

 
 

 
 

 
Corporate debt securities
$

 
$
10,787

 
$
735

 
$
11,522

 
Residential mortgage backed securities

 
3,091

 
17

 
3,108

 
Commercial mortgage backed securities

 
3,618

 

 
3,618

 
State and municipal obligations

 
1,306

 

 
1,306

 
Asset backed securities

 
691

 
389

 
1,080

 
Foreign government bonds and obligations

 
267

 

 
267

 
U.S. government and agency obligations
1

 

 

 
1

 
Total Available-for-Sale securities
1

 
19,760

 
1,141

 
20,902

 
Cash equivalents

 
1,256

 

 
1,256

 
Other assets:
 

 
 

 
 

 
 

 
Interest rate derivative contracts

 
1,451

 

 
1,451

 
Equity derivative contracts
162

 
2,650

 

 
2,812

 
Foreign exchange derivative contracts
1

 
15

 

 
16

 
Credit derivative contracts

 
4

 

 
4

 
Total other assets
163

 
4,120

 

 
4,283

 
Separate account assets at NAV
 
 
 
 
 
 
82,425

(1) 
Total assets at fair value
$
164

 
$
25,136

 
$
1,141

 
$
108,866

 

Liabilities
 

 
 

 
 

 
 

 
Policyholder account balances, future policy benefits and claims:
 

 
 

 
 

 
 

 
Fixed deferred indexed annuity embedded derivatives
$

 
$
3

 
$
43

 
$
46

 
IUL embedded derivatives

 

 
881

 
881

 
GMWB and GMAB embedded derivatives

 

 
763

 
763

(4) 
Total policyholder account balances, future policy benefits and claims

 
3

 
1,687

 
1,690

(5) 
Other liabilities:
 

 
 

 
 

 
 

 
Interest rate derivative contracts

 
418

 

 
418

 
Equity derivative contracts
36

 
3,018

 

 
3,054

 
Foreign exchange derivative contracts
1

 
5

 

 
6

 
Total other liabilities
37

 
3,441

 

 
3,478

 
Total liabilities at fair value
$
37

 
$
3,444

 
$
1,687

 
$
5,168

 
(1) 
Amounts are comprised of certain financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy.
(2) 
The fair value of the GMWB and GMAB embedded derivatives included $3.3 billion of individual contracts in a liability position and $12 million of individual contracts in an asset position as of March 31, 2020.
(3) 
The Company’s adjustment for nonperformance risk resulted in a $(2.7) billion cumulative increase (decrease) to the embedded derivatives as of March 31, 2020.
(4) 
The fair value of the GMWB and GMAB embedded derivatives included $981 million of individual contracts in a liability position and $218 million of individual contracts in an asset position as of December 31, 2019.
(5) 
The Company’s adjustment for nonperformance risk resulted in a $(502) million cumulative increase (decrease) to the embedded derivatives as of December 31, 2019.

25



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis:
 
Available-for-Sale Securities
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Asset Backed Securities
 
Total
(in millions)
 
Balance, January 1, 2020
$
735

 
$
17

 
$
389

 
$
1,141

 
Total gains (losses) included in:
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
(6
)
 

 
(89
)
 
(95
)
 
Purchases
6

 

 

 
6

 
Settlements
(14
)
 

 

 
(14
)
 
Balance, March 31, 2020
$
721

 
$
17

 
$
300

 
$
1,038

 
Changes in unrealized gains (losses) in net income relating to assets held at March 31, 2020
$

 
$

 
$

 
$

 
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at March 31, 2020
$
(6
)
 
$

 
$
(89
)
 
$
(95
)
 
 
Policyholder Account Balances, Future Policy Benefits and Claims
 
Fixed Deferred Indexed Annuity Embedded Derivatives
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Structured Annuity Embedded Derivatives
 
Total
(in millions)
 
Balance, January 1, 2020
$
43

 
$
881

 
$
763

 
$

 
$
1,687

 
Total (gains) losses included in:
 
 
 

 
 

 
 

 
 
 
Net income
(12
)
(1) 
(145
)
(1) 
2,420

(2) 
(3
)
(2) 
2,260

 
Issues
2

 
8

 
88

 
(6
)
 
92

 
Settlements

 
(19
)
 
5

 

 
(14
)
 
Balance, March 31, 2020
$
33

 
$
725

 
$
3,276

 
$
(9
)
 
$
4,025

 
Changes in unrealized (gains) losses in net income relating to liabilities held at March 31, 2020
$

 
$
(145
)
(1) 
$
2,423

(2) 
$

 
$
2,278

 
 
Available-for-Sale Securities
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Asset Backed Securities
 
Total
(in millions)
Balance, January 1, 2019
$
871

 
$
64

 
$
374

 
$
1,309

 
Total gains (losses) included in:
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
14

 

 
5

 
19

 
Settlements
(71
)
 
(1
)
 

 
(72
)
 
Transfers out of Level 3

 
(45
)
 

 
(45
)
 
Balance, March 31, 2019
$
814

 
$
18

 
$
379

 
$
1,211

 
Changes in unrealized gains (losses) in net income relating to assets held at March 31, 2019
$

 
$

 
$

 
$

 

26



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

 
Policyholder Account Balances, Future Policy Benefits and Claims
 
Fixed Deferred Indexed Annuity Embedded Derivatives
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 (in millions)
Balance, January 1, 2019
$
14

 
$
628

 
$
328

 
$
970

 
Total (gains) losses included in:
 
 
 

 
 

 
 
 
Net income
2

(1) 
98

(1) 
(230
)
(2) 
(130
)
 
Issues
7

 
36

 
84

 
127

 
Settlements

 
(17
)
 
(2
)
 
(19
)
 
Balance, March 31, 2019
$
23

 
$
745

 
$
180

 
$
948

 
Changes in unrealized (gains) losses in net income relating to liabilities held at March 31, 2019
$

 
$
98

(1) 
$
(230
)
(2) 
$
(132
)
 
(1) 
Included in interest credited to fixed accounts in the Consolidated Statements of Income.
(2) 
Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income.
The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $1.8 billion and $(158) million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual for the three months ended March 31, 2020 and 2019, respectively.
Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third-party pricing service with observable inputs.
The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:
 
March 31, 2020
Fair 
Value
 
Valuation Technique
 
Unobservable Input
 
Range
 
Weighted
Average
(in millions)
Corporate debt securities (private placements)
$
720
 
Discounted cash flow

Yield/spread to U.S. Treasuries (1)
1.8
%
6.0%
2.8
%
Asset backed securities
$
300
 
Discounted cash flow
Annual default rate
3.8%
3.8
%
 
 
 
Loss severity
25.0%
25.0
%
 
 
 
Yield/spread to swap rates (2)
1,500 bps
2,000 bps
1,528 bps
IUL embedded derivatives
$
725
 
Discounted cash flow
Nonperformance risk (3)
210 bps
210 bps
Fixed deferred indexed annuity embedded derivatives
$
33
 
Discounted cash flow
Surrender rate (4)
0.0
%
50.0%
1.4
%
 
 
 
Nonperformance risk (3)
210 bps
210 bps
GMWB and GMAB embedded derivatives
$
3,276
 
Discounted cash flow

Utilization of guaranteed withdrawals (5) (6)
0.0
%
36.0%
10.8
%
 
 
 
 
Surrender rate (4)
0.1
%
73.5%
3.4
%
 
 
 
 
Market volatility (7) (8)
4.8
%
19.2%
12.6
%
 
 
 
 
Nonperformance risk (3)
210 bps
210 bps
Structured annuity embedded derivatives
$
(9
)
Discounted cash flow
Surrender rate (4)
0.8
%
40.0%
0.9
%
 
 
 
Nonperformance risk (3)
210 bps
210 bps

27



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

 
December 31, 2019
Fair 
Value
 
Valuation Technique
 
Unobservable Input
 
Range
 
Weighted Average
(in millions)
Corporate debt securities
(private placements)
$
735
 
Discounted cash flow

Yield/spread to U.S. Treasuries
0.8
%
2.8%
1.3
%
Asset backed securities
$
389
 
Discounted cash flow
Annual default rate
3.5%
 
 
 
 
Loss severity
25.0%
 
 
 
 
Yield/spread to swap rates
120 bps
170 bps
123 bps
IUL embedded derivatives
$
881
 
Discounted cash flow
Nonperformance risk (3)
65 bps
 
Fixed deferred indexed annuity embedded derivatives
$
43
 
Discounted cash flow

Surrender rate
0.0
%
50.0%
 
 
 
 
Nonperformance risk (3)
65 bps
 
GMWB and GMAB embedded derivatives
$
763
 
Discounted cash flow

Utilization of guaranteed withdrawals (5)
0.0
%
36.0%
 
 
 
 
 
Surrender rate
0.1
%
73.5%
 
 
 
 
 
Market volatility (7)
3.7
%
15.9%
 
 
 
 
 
Nonperformance risk (3)
65 bps
 

(1) The weighted average for the spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security’s market value as a percentage of the aggregate market value of the securities.
(2) The weighted average for the spread to swap rates for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to swap divided by the aggregate balances of the tranches.
(3) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives.
(4) The weighted average surrender rate is weighted based on the benefit base of each contract and represents the average assumption in the current year including the effect of a dynamic surrender formula.
(5) 
The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year.
(6) 
The weighted average utilization rate represents the average assumption for the current year, weighting each policy evenly. The calculation excludes policies that have already started taking withdrawals.
(7) 
Market volatility is implied volatility of fund of funds and managed volatility funds.
(8) 
The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit.
Level 3 measurements not included in the table above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company.
Uncertainty of Fair Value Measurements
Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would have resulted in a significantly lower (higher) fair value measurement.
Significant increases (decreases) in the annual default rate used in the fair value measurement of Level 3 asset backed securities in isolation, generally, would have resulted in a significantly lower (higher) fair value measurement and significant increases (decreases) in loss severity in isolation would have resulted in a significantly lower (higher) fair value measurement.
Significant increases (decreases) in the yield/spread to swap rates in isolation would have resulted in a significantly lower (higher) fair value measurement.
Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would have resulted in a significantly lower (higher) fair value measurement.
Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurements of the fixed deferred indexed annuity embedded derivatives and structured annuity embedded derivatives in isolation would have resulted in a significantly lower (higher) liability value.
Significant increases (decreases) in utilization and volatility used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would have resulted in a significantly higher (lower) liability value.
Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would have resulted in a significantly lower (higher) liability value. Utilization of guaranteed withdrawals and surrender rates vary with the type of rider, the duration of the policy, the age of the contractholder, the distribution channel and whether the value of the guaranteed benefit exceeds the contract accumulation value.

28



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Determination of Fair Value
The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy.
Assets
Cash Equivalents
Cash equivalents include time deposits and other highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less. Actively traded money market funds are measured at their NAV and classified as Level 1. U.S. Treasuries are also classified as Level 1. The Company’s remaining cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization.
Available-for-Sale Securities
When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques.
Level 1 securities primarily include U.S. Treasuries.
Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes.
Level 3 securities primarily include certain corporate bonds, non-agency residential mortgage backed securities and affiliated and unaffiliated asset backed securities. The fair value of corporate bonds, non-agency residential mortgage backed securities and unaffiliated asset backed securities classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote. The fair value of affiliated asset backed securities is determined using a discounted cash flow model. Inputs used to determine the expected cash flows include assumptions about discount rates and default, prepayment and recovery rates of the underlying assets. Given the significance of the unobservable inputs to this fair value measurement, the fair value of the investment in the affiliated asset backed securities is classified as Level 3.
In consideration of the above, management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise.
Separate Account Assets
The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy.
Other Assets
Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial as of both March 31, 2020 and December 31, 2019. See Note 13 and Note 14 for further information on the credit risk of derivative instruments and related collateral.

29



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Liabilities
Policyholder Account Balances, Future Policy Benefits and Claims
There is no active market for the transfer of the Company’s embedded derivatives attributable to the provisions of certain variable annuity riders, fixed deferred index annuity, structured annuity and IUL products.
The Company values the embedded derivatives attributable to the provisions of certain variable annuity riders using internal valuation models. These models calculate fair value as the present value of future expected benefit payments less the present value of future expected rider fees attributable to the embedded derivative feature. The projected cash flows used by these models include observable capital market assumptions and incorporate significant unobservable inputs related to implied volatility as well as contractholder behavior assumptions that include margins for risk, all of which the Company believes a market participant would incorporate into an exit price. The fair value also reflects a current estimate of the Company’s nonperformance risk specific to these embedded derivatives. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims.
The Company uses a discounted cash flow model to determine the fair value of the embedded derivatives associated with the provisions of its equity index annuity product. The projected cash flows generated by this model are based on significant observable inputs related to interest rates, volatilities and equity index levels and, therefore, are classified as Level 2.
The Company uses discounted cash flow models including Black-Scholes calculations to determine the fair value of the embedded derivatives associated with the provisions of its fixed index annuity, structured annuity and IUL products. The structured annuity product is a limited flexible purchase payment annuity that offers 45 different indexed account options providing equity market exposure and a fixed account. Each indexed account includes a protection option (a buffer or a floor). If the index has a negative return, contractholder losses will be reduced by buffer or limited to a floor. The portion allocated to an indexed account is accounted for as an embedded derivative. The fair value of fixed index annuity, structured annuity and IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company’s nonperformance risk. Given the significance of the nonperformance risk assumption to the fair value, the fixed index annuity, structured annuity and IUL embedded derivatives are classified as Level 3.
The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims.
Other Liabilities
Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of both March 31, 2020 and December 31, 2019. See Note 13 and Note 14 for further information on the credit risk of derivative instruments and related collateral.
Fair Value on a Nonrecurring Basis
The Company assesses its investment in affordable housing partnerships for impairment. The investments that are determined to be impaired are written down to their fair value. The Company uses a discounted cash flow model to measure the fair value of these investments. Inputs to the discounted cash flow model are estimates of future net operating losses and tax credits available to the Company and discount rates based on market condition and the financial strength of the syndicator (general partner). The balance of affordable housing partnerships measured at fair value on a nonrecurring basis was $130 million and $158 million as of March 31, 2020 and December 31, 2019, respectively, and is classified as Level 3 in the fair value hierarchy.

30



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

Asset and Liabilities Not Reported at Fair Value
The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:
 
March 31, 2020
 
Carrying
Value
 
Fair Value
Level 1
 
Level 2
 
Level 3
 
Total
(in millions)
Financial Assets
 
 
 
 
 
 
 
 
 
 
Mortgage loans, net
$
2,653

 
$

 
$

 
$
2,617

 
$
2,617

 
Policy loans
869

 

 

 
810

 
810

 
Other investments
418

 

 
265

 
112

 
377

 
Other receivables
1,484

 

 

 
1,647

 
1,647

 
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
 
 
 
 
 
Policyholder account balances, future policy benefits and claims
$
9,075

 
$

 
$

 
$
9,884

 
$
9,884

 
Short-term borrowings
200

 

 
201

 

 
201

 
Other liabilities
17

 

 

 
16

 
16

 
Separate account liabilities — investment contracts
269

 

 
269

 

 
269

 
 
December 31, 2019
 
Carrying
Value
 
Fair Value
Level 1
 
Level 2
 
Level 3
 
Total
(in millions)
Financial Assets
 
 
 
 
 
 
 
 
 
 
Mortgage loans, net
$
2,655

 
$

 
$

 
$
2,707

 
$
2,707

 
Policy loans
867

 

 

 
810

 
810

 
Other investments
410

 

 
376

 
34

 
410

 
Other receivables
1,514

 

 

 
1,648

 
1,648

 
 
 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 
 
 
 
 
 
 
 
 
 
Policyholder account balances, future policy benefits and claims
$
9,110

 
$

 
$

 
$
10,061

 
$
10,061

 
Short-term borrowings
201

 

 
201

 

 
201

 
Line of credit with Ameriprise Financial
50

 

 

 
50

 
50

 
Other liabilities
22

 

 

 
21

 
21

 
Separate account liabilities — investment contracts
340

 

 
340

 

 
340

 

Other investments include syndicated loans and the Company’s membership in the FHLB. Other receivables include the deposit receivable. See Note 7 for additional information on mortgage loans, policy loans, syndicated loans and the deposit receivable.
Policyholder account balances, future policy benefits and claims include fixed annuities in deferral status, non-life contingent fixed annuities in payout status, indexed annuity host contracts and the fixed portion of a small number of variable annuity contracts classified as investment contracts. See Note 9 for additional information on these liabilities. Short-term borrowings include FHLB borrowings. See Note 11 for further information on short-term borrowings. Other liabilities include future funding commitments to affordable housing partnerships and other real estate partnerships. Separate account liabilities are related to certain annuity products that are classified as investment contracts.
13. Offsetting Assets and Liabilities
Certain financial instruments and derivative instruments are eligible for offset in the Consolidated Balance Sheets. The Company’s derivative instruments are subject to master netting and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Consolidated Balance Sheets.

31



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The following tables present the gross and net information about the Company’s assets subject to master netting arrangements:
 
March 31, 2020
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the
Consolidated Balance Sheets
 
Amounts of Assets Presented in the Consolidated Balance Sheets
 
Gross Amounts Not Offset
in the Consolidated Balance Sheets
 
Net Amount
Financial Instruments (1)
 
Cash Collateral
 
Securities Collateral
(in millions)
Derivatives:
 

 
 

 
 

 
 

 
 

 
 

 
 

OTC
$
5,130

 
$

 
$
5,130

 
$
(2,850
)
 
$
(2,006
)
 
$
(273
)
 
$
1

OTC cleared
96

 

 
96

 
(96
)
 

 

 

Exchange-traded
464

 

 
464

 
(25
)
 

 

 
439

Total derivatives
$
5,690

 
$

 
$
5,690

 
$
(2,971
)
 
$
(2,006
)
 
$
(273
)
 
$
440

 
December 31, 2019
Gross Amounts of
Recognized Assets
 
Gross Amounts Offset in the
Consolidated Balance Sheets
 
Amounts of Assets Presented in the Consolidated Balance Sheets
 
Gross Amounts Not Offset
in the Consolidated Balance Sheets
 
Net Amount
Financial Instruments (1)
 
Cash Collateral
 
Securities Collateral
(in millions)
Derivatives:
 

 
 

 
 

 
 

 
 

 
 

 
 

OTC
$
4,181

 
$

 
$
4,181

 
$
(2,886
)
 
$
(1,214
)
 
$
(73
)
 
$
8

OTC cleared
21

 

 
21

 
(21
)
 

 

 

Exchange-traded
81

 

 
81

 
(5
)
 

 

 
76

Total derivatives
$
4,283

 
$

 
$
4,283

 
$
(2,912
)
 
$
(1,214
)
 
$
(73
)
 
$
84

(1) 
Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets.
The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements:
 
March 31, 2020
Gross Amounts of
Recognized Liabilities
 
Gross Amounts Offset in the
Consolidated Balance Sheets
 
Amounts of Liabilities Presented in the Consolidated Balance Sheets
 
Gross Amounts Not Offset
in the Consolidated Balance Sheets
 
Net Amount
Financial Instruments (1)
 
Cash Collateral
 
Securities Collateral
(in millions)
Derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
OTC
$
3,164

 
$

 
$
3,164

 
$
(2,850
)
 
$

 
$
(284
)
 
$
30

OTC cleared
212

 

 
212

 
(96
)
 

 

 
116

Exchange-traded
33

 

 
33

 
(25
)
 

 

 
8

Total derivatives
$
3,409


$


$
3,409


$
(2,971
)

$


$
(284
)

$
154

 
December 31, 2019
Gross Amounts of
Recognized Liabilities
 
Gross Amounts Offset in the
Consolidated Balance Sheets
 
 Amounts of Liabilities Presented in the Consolidated Balance Sheets
 
Gross Amounts Not Offset
in the Consolidated Balance Sheets
 
Net Amount
Financial Instruments (1)
 
Cash Collateral
 
Securities Collateral
(in millions)
Derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
OTC
$
3,426

 
$

 
$
3,426

 
$
(2,886
)
 
$

 
$
(540
)
 
$

OTC cleared
41

 

 
41

 
(21
)
 

 

 
20

Exchange-traded
11

 

 
11

 
(5
)
 

 

 
6

Total derivatives
$
3,478


$


$
3,478


$
(2,912
)

$


$
(540
)

$
26

(1) 
Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets.

32



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

In the tables above, the amount of assets or liabilities presented are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables.
When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral.
Freestanding derivative instruments are reflected in other assets and other liabilities. Cash collateral pledged by the Company is reflected in other assets and cash collateral accepted by the Company is reflected in other liabilities. See Note 14 for additional disclosures related to the Company’s derivative instruments.
14. Derivatives and Hedging Activities
Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations.
Certain of the Company’s freestanding derivative instruments are subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Consolidated Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 13 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral.
The Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives:
 
March 31, 2020
 
December 31, 2019
Notional
 
Gross Fair Value
Notional
 
Gross Fair Value
Assets (1)
 
Liabilities (2)
Assets (1)
 
Liabilities (2)
(in millions)
Derivatives not designated as hedging instruments
 
 
 
 
 
 
 
 
 
 
Interest rate contracts
$
69,208

 
$
3,097

 
$
1,238

 
$
57,950

 
$
1,451

 
$
418

Equity contracts
56,242

 
2,543

 
2,157

 
60,596

 
2,812

 
3,054

Credit contracts
1,654

 
13

 

 
1,386

 
4

 

Foreign exchange contracts
4,200

 
37

 
14

 
3,251

 
16

 
6

Total non-designated hedges
131,304

 
5,690

 
3,409

 
123,183

 
4,283

 
3,478

 
 
 
 
 
 
 
 
 
 
 
 
Embedded derivatives
 
 
 
 
 
 
 
 
 
 
 
GMWB and GMAB (3)
N/A

 

 
3,276

 
N/A

 

 
763

IUL
N/A

 

 
725

 
N/A

 

 
881

Fixed deferred indexed annuities
N/A

 

 
35

 
N/A

 

 
46

Structured annuities
N/A

 

 
(9
)
 
N/A

 

 

Total embedded derivatives
N/A

 

 
4,027

 
N/A

 

 
1,690

Total derivatives
$
131,304

 
$
5,690

 
$
7,436

 
$
123,183

 
$
4,283

 
$
5,168

N/A  Not applicable.
(1) The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets.
(2) The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, indexed annuity and structured annuity embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets.
(3) The fair value of the GMWB and GMAB embedded derivatives as of March 31, 2020 included $3.3 billion of individual contracts in a liability position and $12 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2019 included $981 million of individual contracts in a liability position and $218 million of individual contracts in an asset position.
See Note 12 for additional information regarding the Company’s fair value measurement of derivative instruments.

33



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

As of March 31, 2020 and December 31, 2019, investment securities with a fair value of $296 million and $84 million, respectively, were received as collateral to meet contractual obligations under derivative contracts, of which $296 million and $84 million, respectively, may be sold, pledged or rehypothecated by the Company. As of both March 31, 2020 and December 31, 2019, the Company had sold, pledged, or rehypothecated none of these securities. In addition, as of both March 31, 2020 and December 31, 2019, non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Consolidated Balance Sheets.
The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income:
 
Interest Credited to Fixed Accounts
 
Benefits, Claims, Losses and Settlement Expenses
(in millions)
Three Months Ended March 31, 2020
 
 
 
Interest rate contracts
$

 
$
2,515

Equity contracts
(112
)
 
1,993

Credit contracts

 
(36
)
Foreign exchange contracts

 
44

GMWB and GMAB embedded derivatives

 
(2,513
)
IUL embedded derivatives
164

 

Fixed deferred indexed annuities embedded derivatives
12

 

Structured annuities embedded derivatives

 
3

Total gain (loss)
$
64

 
$
2,006

 
Interest Credited to Fixed Accounts
 
Benefits, Claims, Losses and Settlement Expenses
(in millions)
Three Months Ended March 31, 2019
 
 
 
Interest rate contracts
$

 
$
332

Equity contracts
48

 
(675
)
Credit contracts

 
(29
)
Foreign exchange contracts

 
(6
)
GMWB and GMAB embedded derivatives

 
148

IUL embedded derivatives
(81
)
 

Fixed deferred indexed annuities embedded derivatives
(2
)
 

Total gain (loss)
$
(35
)
 
$
(230
)
The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company.
Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The indexed portion of the structured annuities and the GMAB and non-life contingent GMWB provisions are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. The Company economically hedges the aggregate exposure related to the indexed portion of the structured annuities and the GMAB and non-life contingent GMWB provisions using options, swaptions, swaps and futures.

34



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

The deferred premium associated with certain of the above options and swaptions is paid or received semi-annually over the life of the contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options and swaptions as of March 31, 2020:
 
Premiums Payable
 
Premiums Receivable
(in millions)
2020
(1) 
$
138

 
$
38

2021
152

 
112

2022
203

 
198

2023
126

 
58

2024
70

 
10

2025 - 2028
377

 
7

  Total
$
1,066

 
$
423

(1) 2020 amounts represent the amounts payable and receivable for the period from April 1, 2020 to December 31, 2020.
Actual timing and payment amounts may differ due to future settlements, modifications or exercises of the contracts prior to the full premium being paid or received.
The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. As a means of economically hedging these risks, the Company may use a combination of futures, options, swaps and swaptions. Certain of the macro hedge derivatives may contain settlement provisions linked to both equity returns and interest rates. The Company’s macro hedge derivatives that contain settlement provisions linked to both equity returns and interest rates, if any, are shown in other contracts in the tables above.
Fixed deferred indexed annuity and IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to fixed deferred indexed annuity and IUL products will positively or negatively impact earnings over the life of these products. The equity component of fixed deferred indexed annuity and IUL product obligations are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts.
Cash Flow Hedges
During both the three months ended March 31, 2020 and 2019, the Company held no derivatives that were designated as cash flow hedges. During both the three months ended March 31, 2020 and 2019, no hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy.
Credit Risk
Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting and collateral arrangements whenever practical. See Note 13 for additional information on the Company’s credit exposure related to derivative assets.
Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of the Company’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. As of March 31, 2020 and December 31, 2019, the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $181 million and $189 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of March 31, 2020 and December 31, 2019 was $181 million and $189 million, respectively. If the credit contingent provisions of derivative contracts in a net liability position as of March 31, 2020 and December 31, 2019 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been nil as of both March 31, 2020 and December 31, 2019.

35



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

15. Shareholder’s Equity
The following table provides the amounts related to each component of OCI:
 
Three Months Ended March 31,
2020
 
2019
Pretax
Income Tax Benefit (Expense)
Net of Tax
Pretax
Income Tax Benefit (Expense)
Net of Tax
(in millions)
Net unrealized gains (losses) on securities:
 
 
 
 
 
 
 
 
 
 
 
Net unrealized gains (losses) on securities arising during the period (1)
$
(1,002
)
 
$
212

 
$
(790
)
 
$
599

 
$
(129
)
 
$
470

Reclassification of net (gains) losses on securities included in net income (2)
(8
)
 
2

 
(6
)
 
(10
)
 
2

 
(8
)
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables
508

 
(107
)
 
401

 
(240
)
 
50

 
(190
)
Net unrealized gains (losses) on securities
(502
)
 
107

 
(395
)
 
349

 
(77
)
 
272

Total other comprehensive income (loss)
$
(502
)
 
$
107

 
$
(395
)
 
$
349

 
$
(77
)
 
$
272


(1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period.
(2) Reclassification amounts are recorded in net realized investment gains (losses).
Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit impairments to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.
The following tables present the changes in the balances of each component of AOCI, net of tax:
 
Net Unrealized Gains (Losses) on Securities
 
Other
 
Total
(in millions)
Balance, January 1, 2020
$
575

 
$
(1
)
 
$
574

OCI before reclassifications
(389
)
 

 
(389
)
Amounts reclassified from AOCI
(6
)
 

 
(6
)
Total OCI
(395
)
 

 
(395
)
Balance, March 31, 2020
$
180

(1) 
$
(1
)
 
$
179


 
Net Unrealized Gains (Losses) on Securities
 
Other
 
Total
(in millions)
Balance, January 1, 2019
$
46

 
$
(1
)
 
$
45

OCI before reclassifications
280

 

 
280

Amounts reclassified from AOCI
(8
)
 

 
(8
)
Total OCI
272

 

 
272

Balance, March 31, 2019
$
318

(1) 
$
(1
)
 
$
317


(1) Includes nil and $(5) million of noncredit related impairments on securities and net unrealized gains (losses) on previously impaired securities as of March 31, 2020 and March 31, 2019, respectively.

36



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

16. Income Taxes
The Company’s effective tax rate was 8.5% and 4.6% for the three months ended March 31, 2020 and 2019, respectively.
The effective tax rate for the three months ended March 31, 2020 is lower than the statutory rate primarily due to recent tax law changes that resulted in a $160 million tax benefit related to the forecasted utilization of a 2020 net operating loss (“NOL”) that will be applied to previous tax filings, low income housing tax credits, and other tax preference items. The Company has determined the NOL benefit is attributable to current year losses; accordingly, the benefit is recorded in the annual effective tax rate.
The effective tax rate for the three months ended March 31, 2019 was lower than the statutory rate as a result of tax preferred items including foreign tax credits, low income housing tax credits, and the dividends received deduction, partially offset by lower income in the quarter relative to income expected for the full year.
The increase in the effective tax rate for the three months ended March 31, 2020 compared to the prior year period is primarily the result of higher pretax income, partially offset by the NOL benefit.
Included in the Company’s deferred income tax assets are tax benefits related to state net operating losses of $24 million, net of federal benefit, which will expire beginning December 31, 2020.
The Company is required to establish a valuation allowance for any portion of the deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established, and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination, (i) future taxable income exclusive of reversing temporary differences and carryforwards, (ii) future reversals of existing taxable temporary differences, (iii) taxable income in prior carryback years, and (iv) tax planning strategies. Based on analysis of the Company’s tax position, management believes it is more likely than not that the results of future operations and implementation of tax planning strategies will not allow the Company to realize certain state deferred tax assets of $2 million and state net operating losses of $9 million; therefore, a valuation allowance of $11 million has been established as of both March 31, 2020 and December 31, 2019.
As of March 31, 2020 and December 31, 2019, the Company had $34 million and $39 million, respectively, of gross unrecognized tax benefits. If recognized, approximately $16 million and $17 million, net of federal tax benefits, of unrecognized tax benefits as of March 31, 2020 and December 31, 2019, respectively, would affect the effective tax rate.
It is reasonably possible that the total amount of unrecognized tax benefits will change in the next 12 months. The Company estimates that the total amount of gross unrecognized tax benefits will not decrease in the next 12 months.
The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized nil in interest and penalties for both the three months ended March 31, 2020 and 2019. As of both March 31, 2020 and December 31, 2019, the Company had a payable of $2 million related to accrued interest and penalties.
The Company files income tax returns as part of its inclusion in the consolidated federal income tax returns of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. The federal statute of limitations are closed on years through 2015, except for one issue for 2014 and 2015 which was claimed on amended returns. The Internal Revenue Service (“IRS”) is currently auditing Ameriprise Financial’s U.S. income tax returns for 2016, 2017 and 2018. Ameriprise Financial’s or the Company’s state income tax returns are currently under examination by various jurisdictions for years ranging from 2010 through 2018.

37



RIVERSOURCE LIFE INSURANCE COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) (Continued)

17. Contingencies
Insurance companies have been the subject of increasing regulatory, legislative and judicial scrutiny. Numerous state and federal regulatory agencies have commenced examinations and other inquiries of insurance companies regarding sales and marketing practices (including sales to older consumers and disclosure practices), claims handling, and unclaimed property and escheatment practices and procedures. The Company has cooperated and will continue to cooperate with the applicable regulators.
The Company is involved in the normal course of business in a number of other legal and arbitration proceedings concerning matters arising in connection with the conduct of its business activities. The Company believes that it is not a party to, nor are any of its properties the subject of, any pending legal, arbitration or regulatory investigation, examination or proceeding that is likely to have a material adverse effect on its consolidated financial condition, results of operations or liquidity. Notwithstanding the foregoing, it is possible that the outcome of any current or future legal, arbitration or regulatory proceeding could have a material impact on results of operations in any particular reporting period as the proceedings are resolved.
Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally.
RiverSource Life Insurance Company and RiverSource Life of NY are required by law to be a member of the guaranty fund association in every state where they are licensed to do business. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund associations.
The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations (“NOLHGA”) and the amount of its premiums written relative to the industry-wide premium in each state. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated.
The Company has a liability for estimated guaranty fund assessments and a related premium tax asset. As of both March 31, 2020 and December 31, 2019, the estimated liability was $12 million. As of both March 31, 2020 and December 31, 2019, the related premium tax asset was $10 million. The expected period over which guaranty fund assessments will be made and the related tax credits recovered is not known.

38



RIVERSOURCE LIFE INSURANCE COMPANY

ITEM 2. MANAGEMENT’S NARRATIVE ANALYSIS
Overview
RiverSource Life Insurance Company and its subsidiaries are referred to collectively in this Form 10-Q as the “Company”. The following discussion and management’s narrative analysis of the financial condition and results of operations should be read in conjunction with the “Forward-Looking Statements” that follow, the Consolidated Financial Statements and Notes presented in Item 1 and its Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”) on February 26, 2020 (“2019 10-K”), as well as any current reports on Form 8-K and other publicly available information.
The Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Management’s narrative analysis is presented pursuant to General Instructions H(2)(a) of Form 10-Q in lieu of Management’s Discussion and Analysis of Financial Condition and Results of Operations.
See Note 1 to the Consolidated Financial Statements for additional information.
The coronavirus disease 2019 (‘‘COVID-19’’) pandemic presents ongoing significant economic and societal disruption and market volatility, which have known and yet to be seen impacts to our business and operating environment driven by significant volatility in the interest rate and equity markets and the potential associated implications to client activity. There are no reliable estimates of how long the pandemic will last, how many people are likely to be affected by it, or its impact on the overall economy.
The Company and its affiliates have implemented comprehensive strategies to address the operating environment spurred by the pandemic.  To promote the safety and security of the Company’s employees and to assure the continuity of the Company’s business operations, the Company and its affiliates have implemented a work-from-home protocol for virtually all of the Company’s employee population, restricted business travel, and provided resources for complying with the guidance from the World Health Organization, the U.S. Centers for Disease Control and governments. The Company and its affiliates have been satisfying elevated customer service volumes and the Company’s operations teams have continued to operate successfully and without disruptions in service. The Company’s pandemic strategy is flexible and scalable and takes into consideration that a pandemic could be widespread and may occur in multiple waves, affecting different communities at different times with varying levels of severity.
The Company’s results of operations have been, and will likely continue to be, adversely affected by the COVID-19 pandemic. The uncertainty surrounding the magnitude, duration, speed and reach of the ongoing global pandemic, as well as actions that have been or could be taken by governmental authorities, clients or other third parties, present unknowns that are currently unfolding and will, as they occur, inform any further offsetting or other business adaptation strategies the Company may deploy. The pandemic and its accompanying impact on the global financial markets and on the Company’s operations and financial results will cause results not to be comparable to the same period in previous years. The results presented in this report are not necessarily indicative of future operating results. For further information regarding the impact of COVID-19, and any potentially material effects, please see Item 1A, “Risk Factors” in this report.
Critical Accounting Estimates
The accounting and reporting policies that the Company uses affect its Consolidated Financial Statements. Certain of the Company’s accounting and reporting policies are critical to an understanding of the Company’s financial condition and results of operations. In some cases, the application of these policies can be significantly affected by the estimates, judgments and assumptions made by management during the preparation of the Consolidated Financial Statements. These accounting policies are discussed in detail in “Management’s Narrative Analysis — Critical Accounting Estimates” in the Company’s 2019 10-K.
Recent Accounting Pronouncements
For information regarding recent accounting pronouncements and their expected impact on the Company’s future consolidated financial condition or results of operations, see Note 3 to the Consolidated Financial Statements.

39



RIVERSOURCE LIFE INSURANCE COMPANY

Consolidated Results of Operations for the Three Months Ended March 31, 2020 and 2019
The following table presents the Company’s consolidated results of operations:
 
Three Months Ended
March 31,
 
Change
2020
 
2019
(in millions)
 
 
Revenues
 
 
 
 
 
 
 
Premiums
$
93

 
$
103

 
$
(10
)
 
(10
)%
Net investment income
223

 
256

 
(33
)
 
(13
)
Policy and contract charges
551

 
473

 
78

 
16

Other revenues
119

 
102

 
17

 
17

Net realized investment gains (losses)
(17
)
 
10

 
(27
)
 
NM

Total revenues
969

 
944

 
25

 
3

 
 
 
 
 
 
 
 
Benefits and expenses
 
 
 
 
 
 
 
Benefits, claims, losses and settlement expenses
(1,748
)
 
418

 
(2,166
)
 
NM

Interest credited to fixed accounts
91

 
204

 
(113
)
 
(55
)
Amortization of deferred acquisition costs
503

 
2

 
501

 
NM

Other insurance and operating expenses
163

 
168

 
(5
)
 
(3
)
Total benefits and expenses
(991
)
 
792

 
(1,783
)
 
NM

Pretax income (loss)
1,960

 
152

 
1,808

 
NM

Income tax provision (benefit)
166

 
7

 
159

 
NM

Net income
$
1,794

 
$
145

 
$
1,649

 
NM

NM  Not Meaningful.
Overall
Net income increased $1.6 billion to $1.8 billion for the three months ended March 31, 2020 compared to $145 million for the prior year period. Pretax income increased $1.8 billion to $2.0 billion for the three months ended March 31, 2020 compared to $152 million for the prior year period.
The following impacts were significant drivers of the period-over-period change in pretax income:
The market impact on variable annuity guaranteed benefits (net of hedges and the related deferred sales inducement costs (“DSIC”) and deferred acquisition costs (“DAC”) amortization) was a benefit of $1.7 billion for the three months ended March 31, 2020 compared to an expense of $119 million for the prior year period.
The market impact on indexed universal life (“IUL”) benefits (net of hedges and the related DAC amortization, unearned revenue amortization and the reinsurance accrual) was a benefit of $91 million for the three months ended March 31, 2020 compared to an expense of $51 million for the prior year period.
The impact on variable annuity and variable universal life products for the difference between assumed and updated separate account investment performance on DAC, DSIC, unearned revenue amortization, reinsurance accrual and additional insurance benefit reserves (“mean reversion related impact”) was an expense of $61 million for the three months ended March 31, 2020 compared to a benefit of $36 million for the prior year period.
The Company’s variable annuity account balances declined 9% to $70.0 billion as of March 31, 2020 compared to the prior year period reflecting net outflows of $3.0 billion and market depreciation. Variable annuity sales increased 24% compared to the prior year period reflecting changes in product offerings.
The Company’s fixed deferred annuity account balances declined 5% to $8.2 billion as of March 31, 2020 compared to the prior year period as older policies continue to lapse and new sales are limited due to low interest rates. The Company reinsured approximately 20% of its fixed annuities block during the first quarter of 2019.
Revenues
Premiums decreased $10 million or 10% to $93 million for the three months ended March 31, 2020 compared to $103 million for the prior year period reflecting lower sales of immediate annuities with a life contingent feature.
Net investment income decreased $33 million or 13% to $223 million for the three months ended March 31, 2020 compared to $256 million for the prior year period reflecting a decrease in investment income on fixed maturities due to lower yields as a result of lower interest rates and a decrease in average invested assets due to fixed annuity net outflows and the unfavorable impact from the fixed annuities reinsurance transaction.

40



RIVERSOURCE LIFE INSURANCE COMPANY

Policy and contract charges increased $78 million or 16% to $551 million for the three months ended March 31, 2020 compared to $473 million for the prior year period primarily due to the unearned revenue amortization and the reinsurance accrual offset to the market impact of IUL benefits, which was a benefit of $55 million for the three months ended March 31, 2020 compared to an expense of $17 million for the prior year period.
Other revenues increased $17 million or 17% to $119 million for the three months ended March 31, 2020 compared to $102 million for the prior year period primarily due to accretion on the fixed annuities reinsurance deposit receivable.
Net realized investment losses were $17 million for the three months ended March 31, 2020 compared to net realized investment gains of $10 million for the prior year period. For the three months ended March 31, 2020, net realized gains of $4 million on Available-for-Sale securities due to sales, calls and tenders were more than offset by an increase in the allowance for credit losses of $13 million primarily related to credit losses on corporate debt securities and an increase of $9 million in the provision for commercial mortgage loans and syndicated loans. For the three months ended March 31, 2019, net realized gains on Available-for-Sale securities due to sales, calls and tenders were $10 million.
Benefits and Expenses
Benefits, claims, losses and settlement expenses decreased $2.2 billion to a benefit of $1.7 billion for the three months ended March 31, 2020 compared to an expense of $418 million for the prior year period primarily reflecting the following items:
A $1.7 billion decrease in expense from the unhedged nonperformance credit spread risk adjustment on variable annuity guaranteed benefits. The favorable impact of the nonperformance credit spread was $1.6 billion for the three months ended March 31, 2020 compared to an unfavorable impact of $158 million for the prior year period. As the estimate of the nonperformance credit spread over the LIBOR swap curve tightens or widens, the embedded derivative liability will increase or decrease. As the embedded derivative liability on which the nonperformance credit spread is applied increases (decreases), the impact of the nonperformance credit spread is favorable (unfavorable) to expense. The estimated nonperformance credit spread widened by 145 basis points in the quarter due to the recent market dislocation related to the COVID-19 pandemic, resulting in the favorable impact.
A $502 million decrease in expense from other market impacts on variable annuity guaranteed benefits, net of hedges in place to offset those risks and the related DSIC amortization. This decrease was the result of a favorable $4.9 billion change in the market impact on derivatives hedging the variable annuity guaranteed benefits, an unfavorable $4.4 billion change in the market impact on variable annuity guaranteed living benefits reserves and a favorable $6 million change in the DSIC offset. The main market drivers contributing to these changes are summarized below:
Equity market impact on the variable annuity guaranteed living benefits liability net of the impact on the corresponding hedge assets resulted in a benefit for the three months ended March 31, 2020 compared to an expense for the prior year period.
Interest rate impact on the variable annuity guaranteed living benefits liability net of the impact on the corresponding hedge assets resulted in a benefit for the three months ended March 31, 2020 compared to an expense for the prior year period.
Volatility impact on the variable annuity guaranteed living benefits liability net of the impact on the corresponding hedge assets resulted in a higher expense for the three months ended March 31, 2020 compared to the prior year period.
Other unhedged items, including the difference between the assumed and actual underlying separate account investment performance, fixed income credit exposures, transaction costs and various behavioral items, were a net unfavorable impact compared to the prior year period.
The mean reversion related impact was an expense of $24 million for the three months ended March 31, 2020 compared to a benefit of $16 million for the prior year period.
Interest credit to fixed accounts decreased $113 million or 55% to $91 million for the three months ended March 31, 2020 compared to $204 million for the prior year period primarily reflecting the following items:
A $271 million decrease in expense from the unhedged nonperformance credit spread risk adjustment on IUL benefits. The favorable impact of the nonperformance credit spread was $234 million for the three months ended March 31, 2020 compared to an unfavorable impact of $37 million for the prior year period. As the estimate of the nonperformance credit spread over the LIBOR swap curve tightens or widens, the embedded derivative liability will increase or decrease. As the embedded derivative liability on which the nonperformance credit spread is applied increases (decreases), the impact of the nonperformance credit spread is favorable (unfavorable) to expense. The estimated nonperformance credit spread widened by 145 basis points in the quarter due to the recent market dislocation related to the COVID-19 pandemic, resulting in the favorable impact.
A $160 million increase in expense from other market impacts on IUL benefits, net of hedges, which was an expense of $166 million for the three months ended March 31, 2020 compared to an expense of $6 million for the prior year period. The increase in expense was primarily due to a decrease in the discount rate, excluding the nonperformance credit spread, used to value the liabilities.
Amortization of DAC increased $501 million to $503 million for the three months ended March 31, 2020 compared to $2 million for the prior year period primarily reflecting the following items:
The DAC offset to the market impact on variable annuity guaranteed benefits was an expense of $384 million for the three months ended March 31, 2020 compared to a benefit of $25 million for the prior year period.

41



RIVERSOURCE LIFE INSURANCE COMPANY

The DAC offset to the market impact on IUL benefits was an expense of $32 million for the three months ended March 31, 2020 compared to a benefit of $9 million for the prior year period.
The mean reversion related impact was an expense of $36 million for the three months ended March 31, 2020 compared to a benefit of $20 million for the prior year period.
Income Taxes
The Company’s effective tax rate was 8.5% for the three months ended March 31, 2020 compared to 4.6% for the prior year period. The increase in the effective tax rate for the quarter ended March 31, 2020 compared to the prior year period is primarily due to higher pretax income, partially offset by recent tax law changes that resulted in a $160 million tax benefit related to the forecasted utilization of a 2020 net operating loss (“NOL”) that will be applied to previous tax filings. See Note 16 to the Consolidated Financial Statements for additional discussion on income taxes.
Market Risk
The Company’s primary market risk exposures are interest rate, equity price and credit risk. Equity price and interest rate fluctuations can have a significant impact on the Company’s results of operations, primarily due to the effects on asset-based fees and expenses, the “spread” income generated on its fixed deferred annuities, fixed insurance and the fixed portion of its variable annuities and variable insurance contracts, the value of DAC and DSIC assets, the value of liabilities for guaranteed benefits associated with its variable annuities and the value of derivatives held to hedge these benefits.
The Company’s earnings from fixed deferred annuities, fixed insurance, and the fixed portion of variable annuities and variable insurance contracts are based upon the spread between rates earned on assets held and the rates at which interest is credited to accounts. The Company primarily invests in fixed rate securities to fund the rate credited to clients. The Company guarantees an interest rate to the holders of these products. Investment assets and client liabilities generally differ as it relates to basis, repricing or maturity characteristics. Rates credited to clients’ accounts generally reset at shorter intervals than the yield on the underlying investments. Therefore, in an increasing interest rate environment, higher interest rates may be reflected in crediting rates to clients sooner than in rates earned on invested assets, which could result in a reduced spread between the two rates, reduced earned income and a negative impact on pretax income. However, the current low interest rate environment is resulting in interest rates below the level of some of the Company’s liability guaranteed minimum interest rates (“GMIRs”). Hence, a modest rise in interest rates would not necessarily result in changes to all the liability credited rates while projected asset purchases would capture the full increase in interest rates. This dynamic would result in widening spreads under a modestly rising rate scenario given the current relationship between the current level of interest rates and the underlying GMIRs on the business.
As a result of the low interest rate environment, the Company’s current reinvestment yields are generally lower than the current portfolio yield. The Company expects its portfolio income yields to continue to decline in future periods if interest rates remain low. The carrying value and weighted average yield of total non-structured fixed maturity securities and commercial mortgage loans in the Company’s investment portfolio that may generate proceeds to reinvest through March 31, 2021 due to prepayment, maturity or call activity at the option of the issuer, excluding securities with a make-whole provision, were $1.4 billion and 4.3%, respectively, as of March 31, 2020. In addition, residential mortgage-backed securities, which are subject to prepayment risk as a result of the low interest rate environment, totaled $3.2 billion and had a weighted average yield of 2.9% as of March 31, 2020. While these amounts represent investments that could be subject to reinvestment risk, it is also possible that these investments will be used to fund liabilities or may not be prepaid and will remain invested at their current yields. In addition to the interest rate environment, the mix of benefit payments versus product sales as well as the timing and volumes associated with such mix may impact the Company’s investment yield. Furthermore, reinvestment activities and the associated investment yield may also be impacted by corporate strategies implemented at management’s discretion. The average yield for investment purchases during the three months ended March 31, 2020 was approximately 2.5%.
The reinvestment of proceeds from maturities, calls and prepayments at rates below the current portfolio yield, which may be below the level of some liability GMIRs, will have a negative impact to future operating results. To mitigate the unfavorable impact that the low interest rate environment has on the Company’s spread income, it assesses reinvestment risk in its investment portfolio and monitors this risk in accordance with its asset/liability management framework. In addition, the Company may reduce the crediting rates on its fixed products when warranted, subject to guaranteed minimums.
In addition to the fixed rate exposures noted above, the Company also has the following variable annuity guarantee benefits: guaranteed minimum withdrawal benefits (“GMWB”), guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum death benefits (“GMDB”) and guaranteed minimum income benefits (“GMIB”). Each of these benefits guarantees payouts to the annuity holder under certain specific conditions regardless of the performance of the underlying invested assets.
The variable annuity guarantees continue to be managed by utilizing a hedging program which attempts to match the sensitivity of the assets with the sensitivity of the liabilities. This approach works with the premise that matched sensitivities will produce a highly effective hedging result. The Company’s comprehensive hedging program focuses mainly on first order sensitivities of assets and liabilities: Equity Market Level (Delta), Interest Rate Level (Rho) and Volatility (Vega). Additionally, various second order sensitivities are managed. The Company uses various options, swaptions, swaps and futures to manage risk exposures. The exposures are measured and monitored daily and adjustments to the hedge portfolio are made as necessary.
The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity

42



RIVERSOURCE LIFE INSURANCE COMPANY

reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. The Company assesses this residual risk under a range of scenarios in creating and executing the macro hedge program. As a means of economically hedging these risks, the Company may use a combination of futures, options, swaps and swaptions. Certain of the macro hedge derivatives used contain settlement provisions linked to both equity returns and interest rates; the remaining are interest rate contracts or equity contracts. The macro hedge program could result in additional earnings volatility as changes in the value of the macro hedge derivatives, which are designed to reduce statutory capital volatility, may not be closely aligned to changes in the variable annuity guarantee embedded derivatives.
To evaluate interest rate and equity price risk, the Company performs sensitivity testing which measures the impact on pretax income from the sources listed below for a 12-month period following a hypothetical 100 basis point increase in interest rates or a hypothetical 10% decline in equity prices. The interest rate risk test assumes a sudden 100 basis point parallel shift in the yield curve, with rates then staying at those levels for the next 12 months. The equity price risk test assumes a sudden 10% drop in equity prices, with equity prices then staying at those levels for the next 12 months. In estimating the values of variable annuities, fixed deferred indexed annuities, IUL insurance and the associated hedge assets, the Company assumed no change in implied market volatility despite the 10% drop in equity prices.
The following tables present the Company’s estimate of the impact on pretax income from the above defined hypothetical market movements as of March 31, 2020:
Equity Price Decline 10%
 
Equity Price Exposure to Pretax Income
Before Hedge Impact
Hedge Impact
Net Impact
 
 
(in millions)
Asset-based fees and expenses
 
$
(52
)
 
$

 
$
(52
)
DAC and DSIC amortization (1) (2)
 
(25
)
 

 
(25
)
Variable annuities:
 
 

 
 

 
 
GMDB and GMIB (2)
 
(28
)
 

 
(28
)
GMWB (2)
 
(644
)
 
749

 
105

GMAB
 
(39
)
 
37

 
(2
)
Structured annuities
 
7

 
(6
)
 
1

DAC and DSIC amortization (3)
 
N/A

 
N/A

 
18

Total variable annuities
 
(704
)

780


94

Macro hedge program (4)
 

 
88

 
88

Fixed deferred indexed annuities
 
2

 
(2
)
 

IUL insurance
 
22

 
(18
)
 
4

Total
 
$
(757
)

$
848


$
109

Interest Rate Increase 100 Basis Points
 
Interest Rate Exposure to Pretax Income
Before Hedge Impact
Hedge Impact
Net Impact
 
 
(in millions)
Asset-based fees and expenses
 
$
(16
)
 
$

 
$
(16
)
Variable annuities:
 
 

 
 

 
 

GMDB and GMIB
 

 

 

GMWB
 
1,367

 
(2,064
)
 
(697
)
GMAB
 
25

 
(36
)
 
(11
)
Structured annuities
 
(3
)
 
3

 

DAC and DSIC amortization (3)
 
N/A

 
N/A

 
75

Total variable annuities
 
1,389


(2,097
)

(633
)
Macro hedge program (4)
 

 
(2
)
 
(2
)
Fixed deferred indexed annuities
 
(1
)
 

 
(1
)
Fixed annuities, fixed insurance and fixed portion of variable annuities and variable insurance products
 
59

 

 
59

IUL insurance
 
12

 
2

 
14

Total
 
$
1,443


$
(2,097
)

$
(579
)
N/A Not Applicable.

43



RIVERSOURCE LIFE INSURANCE COMPANY

(1) 
Market impact on DAC and DSIC amortization resulting from lower projected profits.
(2) 
In estimating the impact to pretax income on DAC and DSIC amortization and additional insurance benefit reserves, the assumed equity asset growth rates reflect what management would follow in its mean reversion guidelines.
(3) 
Market impact on DAC and DSIC amortization related to variable annuity riders is modeled net of hedge impact.
(4) 
The market impact of the macro hedge program is modeled net of any related impact to DAC and DSIC amortization.
The above results compare to an estimated positive net impact to pretax income of $103 million related to a 10% equity price decline and an estimated negative net impact to pretax income of $91 million related to a 100 basis point increase in interest rates as of December 31, 2019. The change in equity price exposure and interest rate exposure as of March 31, 20120 compared to December 31, 2019 was driven by a larger estimated negative impact from our variable annuity riders specifically GMWB.
Net impacts shown in the above table from GMWB riders result largely from differences between the liability valuation basis and the hedging basis. Liabilities are valued using fair value accounting principles, with risk margins incorporated in contractholder behavior assumptions and with discount rates increased to reflect a current market estimate of the Company’s risk of nonperformance specific to these liabilities. The Company’s hedging is based on its determination of economic risk, which excludes certain items in the liability valuation including the nonperformance spread risk.
Actual results could differ materially from those illustrated above as they are based on a number of estimates and assumptions. These include assuming that implied market volatility does not change when equity prices fall by 10% and that the 100 basis point increase in interest rates is a parallel shift of the yield curve. Furthermore, the Company has not tried to anticipate changes in client preferences for different types of assets or other changes in client behavior, nor has the Company tried to anticipate all strategic actions management might take to increase revenues or reduce expenses in these scenarios.
The selection of a 100 basis point interest rate increase as well as a 10% equity price decline should not be construed as a prediction of future market events. Impacts of larger or smaller changes in interest rates or equity prices may not be proportional to those shown for a 100 basis point increase in interest rates or a 10% decline in equity prices.
Fair Value Measurements
The Company reports certain assets and liabilities at fair value; specifically, separate account assets, derivatives, embedded derivatives, most investments and cash equivalents. Fair value assumes the exchange of assets or liabilities occurs in orderly transactions and is not the result of a forced liquidation or distressed sale. The Company includes actual market prices, or observable inputs, in its fair value measurements to the extent available. Broker quotes are obtained when quotes from pricing services are not available. The Company validates prices obtained from third parties through a variety of means such as: price variance analysis, subsequent sales testing, stale price review, price comparison across pricing vendors and due diligence reviews of vendors. See Note 12 to the Consolidated Financial Statements for additional information on the Company’s fair value measurements.
Fair Value of Liabilities and Nonperformance Risk
Companies are required to measure the fair value of liabilities at the price that would be received to transfer the liability to a market participant (an exit price). Since there is not a market for the Company’s obligations of its variable annuity riders, indexed annuities and IUL insurance, the Company considers the assumptions participants in a hypothetical market would make to reflect an exit price. As a result, the Company adjusts the valuation of variable annuity riders, indexed annuities and IUL insurance by updating certain contractholder assumptions, adding explicit margins to provide for profit, risk and expenses, and adjusting the rates used to discount expected cash flows to reflect a current market estimate of the Company’s nonperformance risk. The nonperformance risk adjustment is based on observable market data adjusted to estimate the risk of the Company not fulfilling these liabilities. Consistent with general market conditions, this estimate resulted in a spread over the LIBOR swap curve as of March 31, 2020. As the Company’s estimate of this spread widens or tightens, the liability will decrease or increase. If this nonperformance credit spread moves to a zero spread over the LIBOR swap curve, the reduction to future net income would be approximately $1.8 billion, net of DAC, DSIC, unearned revenue amortization, the reinsurance accrual and income taxes (calculated at the statutory tax rate of 21%), based on March 31, 2020 credit spreads.
Liquidity and Capital Resources
Liquidity Strategy
The liquidity requirements of the Company are generally met by funds provided by investment income, maturities and periodic repayments of investments, premiums and proceeds from sales of investments, fixed annuity and fixed insurance deposits as well as capital contributions from its parent, Ameriprise Financial Inc. (“Ameriprise Financial”). Other liquidity sources the Company has established are short-term borrowings and available lines of credit with Ameriprise Financial aggregating $992 million.
The Company enters into short-term borrowings, which may include repurchase agreements and Federal Home Loan Bank (“FHLB”) advances to reduce reinvestment risk. Short-term borrowings allow the Company to receive cash to reinvest in longer-duration assets, while maintaining the flexibility to pay back the short-term debt with cash flows generated by the fixed income portfolio. RiverSource Life Insurance Company is a member of the FHLB of Des Moines, which provides RiverSource Life Insurance Company access to collateralized borrowings. As of both March 31, 2020 and December 31, 2019, the Company had estimated maximum borrowing capacity of $6.2 billion under the FHLB facility, of which $200 million was outstanding and is collateralized with commercial mortgage backed securities as of both March 31, 2020 and December 31, 2019.
The primary uses of funds are policy benefits, commissions, other product-related acquisition and sales inducement costs, operating expenses, policy loans, dividends to Ameriprise Financial and investment purchases. The Company routinely reviews its sources and uses of funds in order to meet its ongoing obligations.

44



RIVERSOURCE LIFE INSURANCE COMPANY

In 2009, the Company established an agreement to protect its exposure to Genworth Life Insurance Company (“GLIC”) for its reinsured long term care (“LTC”). In 2016, substantial enhancements to this reinsurance protection agreement were finalized. The terms of these confidential provisions within the agreement have been shared, in the normal course of regular reviews, with the Company’s domiciliary regulator and rating agencies. GLIC is domiciled in Delaware so in the event GLIC were subjected to rehabilitation or insolvency proceedings, such proceedings would be located in (and governed by) Delaware laws. Delaware courts have a long tradition of respecting commercial and reinsurance affairs as well as contracts among sophisticated parties. Similar credit protections to what the Company has with GLIC have been tested and respected in Delaware and elsewhere in the United States, and as a result the Company believes its credit protections would be respected even in the unlikely event that GLIC becomes subject to rehabilitation or insolvency proceedings in Delaware. Accordingly, while no credit protections are perfect, the Company believes the correct way to think about the risks represented by its counterparty credit exposure to GLIC is not the full amount of the gross liability that GLIC reinsures, but a much smaller net exposure to GLIC (if any that might exist after taking into account the Company’s credit protections). Thus, management believes that this agreement and offsetting non LTC legacy arrangements with Genworth will enable the Company to recover on all net exposure in all material respects in the event of a rehabilitation or insolvency of GLIC.
Capital Activity
Cash dividends or distributions paid and received by RiverSource Life Insurance Company were as follows:
 
Three Months Ended
March 31,
2020
 
2019
(in millions)
Paid to Ameriprise Financial
$
250

 
$
250

For dividends or distributions from the life insurance companies, notifications to state insurance regulators were made in advance of payments in excess of statutorily defined thresholds.
Regulatory Capital
RiverSource Life Insurance Company and RiverSource Life of NY are subject to regulatory capital requirements. Actual capital, determined on a statutory basis, and regulatory capital requirements for each of the life insurance entities were as follows:
 
Actual Capital (1)
 
Regulatory Capital 
Requirements (2)
March 31,
2020
 
December 31,
2019
December 31,
2019
(in millions)
RiverSource Life Insurance Company
$
3,548

 
$
2,924

 
$
601

RiverSource Life Insurance Co. of NY
343

 
235

 
38

(1) Actual capital, as defined by the National Association of Insurance Commissioners for purposes of meeting regulatory capital requirements, includes statutory capital and surplus, plus certain statutory valuation reserves.
(2) Regulatory capital requirement is the company action level and is based on the statutory risk-based capital filing.
Contractual Commitments
There have been no material changes to the Company’s contractual obligations disclosed in the Company’s 2019 10-K.

45



RIVERSOURCE LIFE INSURANCE COMPANY

Forward-Looking Statements
This report contains forward-looking statements that reflect the Company’s plans, estimates and beliefs. The Company’s actual results could differ materially from those described in these forward-looking statements. Examples of such forward-looking statements include: 
statements of the Company’s plans, intentions, expectations, objectives, or goals, including those related to the introduction, cessation, terms or pricing of new or existing products and services and the consolidated tax rate;
statements of the Company’s position, future performance and ability to pursue business strategy relative to the spread and impact of the COVID-19 pandemic and the related market, economic, client, governmental and healthcare system response; 
other statements about future economic performance, the performance of equity markets and interest rate variations and the economic performance of the United States and of global markets; and
statements of assumptions underlying such statements.
The words “believe,” “expect,” “anticipate,” “optimistic,” “intend,” “plan,” “aim,” “will,” “may,” “should,” “could,” “would,” “likely,” “forecast,” “on track,” “project,” “continue,” “able to remain,” “resume,” “deliver,” “develop,” “evolve,” “drive,” “enable,” “flexibility,” “scenario,” “case” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from such statements.
Such factors include, but are not limited to: 
the impacts on the Company’s business of the spread and impact of the COVID-19 pandemic and the related economic, client, governmental and healthcare system responses;
conditions in the interest rate, credit default, equity market and foreign exchange environments, including changes in valuations, liquidity and volatility;
changes in and the adoption of relevant accounting standards and securities rating agency standards and processes, as well as changes in the litigation and regulatory environment, including ongoing legal proceedings and regulatory actions, the frequency and extent of legal claims threatened or initiated by clients, other persons and regulators, and developments in regulation and legislation, including the rules and regulations implemented or that may be implemented or modified in connection with the Dodd-Frank Wall Street Reform and Consumer Protection Act, bank holding company laws and regulations or in light of the U.S. Department of Labor’s fiduciary regulations (as well as state and other fiduciary rules, the Securities and Exchange Commission best interest standards, or similar standards as the Certified Financial Planner Board standards) pertaining to the fiduciary status of investment advice providers to 401(k) plans, plan sponsors, plan participants and the holders of individual retirement or health savings accounts and related issues;
the Company’s investment management performance and consumer acceptance of the Company’s products;
effects of competition in the financial services industry, including pricing pressure, the introduction of new products and services and changes in product distribution mix and distribution channels;
changes to the Company’s reputation that may arise from employee or Ameriprise Financial Services, Inc. advisor misconduct, legal or regulatory actions, cybersecurity incidents, improper management of conflicts of interest or otherwise;
the Company’s capital structure as a subsidiary of Ameriprise Financial, including the ability of its parent to support its financial strength and ratings, as well as the opinions of rating agencies and other analysts or the Company’s regulators, distributors or policyholders and contractholders in response to any change or prospect of change in any such opinion;
risks of default, capacity constraint or repricing by issuers or guarantors of investments the Company owns or by counterparties to hedge derivative, insurance or reinsurance arrangements, experience deviations from the Company’s assumptions regarding such risks, the evaluations or the prospect of changes in evaluations of any such third parties published by rating agencies or other analysts and the reactions of other market participants or the Company’s regulators, distribution partners or customers in response to any such evaluation or prospect of changes in evaluation;
experience deviations from the Company’s assumptions regarding morbidity, mortality, persistency and premium rate increases in certain annuity and insurance products (including, but not limited to, variable annuities and long term care policies), or from assumptions regarding market returns assumed in valuing or unlocking DAC and DSIC or market volatility underlying the Company’s valuation and hedging of guaranteed benefit annuity riders, or from assumptions regarding interest rates or asset yield assumed in the Company’s loss recognition testing of its long term care business;
successfully cross-selling insurance and annuity products and services to Ameriprise Financial’s customer base;
the Company’s ability to effectively hedge risks relating to guaranteed benefit riders and certain other products;
the impact of intercompany allocations to the Company from Ameriprise Financial and its affiliates;
Ameriprise Financial’s ability to attract, recruit and retain qualified advisors and employees and its ability to distribute the Company’s products through current and future distribution channels;
changes in capital requirements that may be indicated, required or advised by regulators or rating agencies;
the impacts of Ameriprise Financial’s efforts to improve distribution economics and realize benefits from re-engineering and tax planning;

46



RIVERSOURCE LIFE INSURANCE COMPANY

interruptions or other failures in the Company’s communications, technology and other operating systems, including errors or failures caused by third-party service providers, interference or failures caused by third-party attacks on the Company’s systems (or other cybersecurity incidents), or the failure to safeguard the privacy or confidentiality of sensitive information and data on such systems; and
general economic and political factors, including consumer confidence in the economy, the ability and inclination of consumers generally to invest, as well as their ability and inclination to invest in financial instruments and products other than cash and cash equivalents, the costs of products and services the Company consumes in the conduct of its business, and applicable legislation and regulation and changes therein, including tax laws, tax treaties, fiscal and central government treasury policy, and policies regarding the financial services industry and regulatory rulings and pronouncements.
The Company cautions the reader that the foregoing list of factors is not exhaustive. There may also be other risks that the Company is unable to predict at this time that may cause actual results to differ materially from those in forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update publicly or revise any forward-looking statements. The foregoing list of factors should be read in conjunction with the “Risk Factors” discussion included in Part I, Item 1A of the Company’s 2019 10-K and “Item 1A. Risk Factors” in this Form 10-Q.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) designed to provide reasonable assurance that the information required to be reported in the Exchange Act filings is recorded, processed, summarized and reported within the time periods specified in and pursuant to Securities and Exchange Commission regulations, including controls and procedures designed to ensure that this information is accumulated and communicated to the Company’s management, including its principal executive officer and chief financial officer, as appropriate, to allow timely decisions regarding the required disclosure. It should be noted that, because of inherent limitations, the Company’s disclosure controls and procedures, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the disclosure controls and procedures are met.
The Company’s management, under the supervision and with the participation of the Company’s principal executive officer and chief financial officer, evaluated the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the Company’s principal executive officer and chief financial officer have concluded that the Company’s disclosure controls and procedures were effective at a reasonable level of assurance as of March 31, 2020.
Changes in Internal Control over Financial Reporting
There have not been any changes in RiverSource Life Insurance Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, RiverSource Life Insurance Company’s internal control over financial reporting.

47



RIVERSOURCE LIFE INSURANCE COMPANY

PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The information set forth in Note 17 to the Consolidated Financial Statements in Part I, Item 1 is incorporated herein by reference. 
ITEM 1A. RISK FACTORS
The Company is including the following new risk factor which should be read in conjunction with the risk factors provided in Part I, Item 1A of RiverSource Life Insurance Company’s 2019 10-K.
The COVID-19 pandemic creates significant risks and uncertainties for RiverSource Life’s business.
The ongoing coronavirus disease 2019 (‘‘COVID-19’’) pandemic creates significant and pervasive societal, economic and market disruption globally. The extent to which the COVID-19 pandemic impacts RiverSource Life’s business, results of operations, and financial condition will depend on future developments. These developments are highly uncertain, including the scope, duration and severity of the pandemic, the effectiveness of RiverSource Life’s remote working and virtual meeting arrangements and staffing levels, the measures that may be taken by various governmental authorities in response to the outbreak (such as stimulus, quarantines and travel restrictions, effectiveness of health care and new or interim regulation, including mandated premium grace periods or other additional compliance requirements for insurance businesses), the actions of other third parties in response to the pandemic, and the possible further impacts on the global economy. While additional net death claims for RiverSource Life could increase within its individual life insurance business as a result of COVID-19, any additional death claims could be offset to the extent of any reductions in benefit liabilities under its long term care insurance, payout annuity and variable annuity living benefit blocks. Given the uncertainty of future developments, RiverSource Life seeks to manage its risks effectively, but its ability to do so is subject to the inherent limitations of obtaining timely, reliable analysis and information in a situation that continues to develop.
Towards the end of the first quarter of 2020 and into April 2020, the COVID-19 pandemic impacted RiverSource Life and impact would likely be experienced in future quarters if conditions persist. Consumer demand, investment income, owned asset values, and RiverSource Life’s credit reserve and other financial or actuarial assumptions and reserve calculations have been (and may further be) negatively impacted from a decline and volatility of asset prices, reduction in interest rates, widening of credit spreads, credit deterioration, decreased liquidity in trading markets and other economic and market effects of the global pandemic. Should these conditions be prolonged or worsen for an extended time period, RiverSource Life could experience volatility and uncertainty in volumes, uncertainty in availability and price levels of financial assets and hedges, reduced customer activity and fees, increased mortality and morbidity in its policyholder base, increased constraints and costs of capital, possible impacts to RiverSource Life’s ratings and other negative impacts on RiverSource Life’s financial position. Moreover, the COVID-19 pandemic may impact the ability of service providers to continue ordinary business operations and technology functions over near- or longer-term periods.
The COVID-19 pandemic may also affect the ability of RiverSource Life’s suppliers, distributors, vendors, reinsurers and other counterparties to provide products and services and otherwise fulfill their commitments to RiverSource Life. With the majority of its life insurance death benefit risk reinsured to major U.S. reinsurers, RiverSource Life manages and monitors the counterparty risk associated with these reinsurers through rigorous counterparty relationship standards (reinsurers currently receiving any new life or disability income reinsurance business are currently rated at least A+ by A.M. Best and AA- by Standard and Poor’s).
In addition, the market and economic uncertainty and the effects of the COVID-19 pandemic will heighten the other risks described in the section entitled “Risk Factors” in RiverSource Life’s most recent Annual Report on Form 10-K and any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K.

48



RIVERSOURCE LIFE INSURANCE COMPANY

ITEM 6. EXHIBITS
The following exhibits are filed as part of this Quarterly Report:
Exhibit
Description
 
 
3.1  
Copy of Certificate of Incorporation of IDS Life Insurance Company, filed as Exhibit 3.1 to Post-Effective Amendment No. 5 to Registration Statement No. 33-28976, is incorporated by reference.
Copy of Certificate of Amendment of Certificate of Incorporation of IDS Life Insurance Company dated June 22, 2006, filed as Exhibit 3.1 to Form 8-K filed on January 5, 2007, is incorporated by reference.
Copy of Amended and Restated By-Laws of RiverSource Life Insurance Company dated June 22, 2006, filed as Exhibit 27(f)(2) to Post-Effective Amendment No. 28 to Registration Statement No. 333-69777, is incorporated by reference.
Certification of John R. Woerner, Chairman and President, pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
Certification of Brian J. McGrane, Chief Financial Officer, pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
Certification of John R. Woerner, Chairman and President, and Brian J. McGrane, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101
The following materials from RiverSource Life Insurance Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at March 31, 2020 and December 31, 2019; (ii) Consolidated Statements of Income for the three months ended March 31, 2020 and 2019; (iii) Consolidated Statements of Comprehensive Income for the three months ended March 31, 2020 and 2019; (iv) Consolidated Statements of Equity for the three months ended March 31, 2020 and 2019; (v) Consolidated Statements of Cash Flows for the three months ended March 31, 2020 and 2019; and (vi) Notes to the Consolidated Financial Statements.
104
The cover page from RiverSource Life Insurance Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020 is formatted in iXBRL and contained in Exhibit 101.
* Filed electronically herewithin.


49



RIVERSOURCE LIFE INSURANCE COMPANY

 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
RIVERSOURCE LIFE INSURANCE COMPANY
(Registrant)
Date:
May 11, 2020
By:
/s/ John R. Woerner
 
John R. Woerner
Chairman and President
Date:
May 11, 2020
By:
/s/ Brian J. McGrane
 
Brian J. McGrane
Executive Vice President and Chief Financial Officer



50